<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4261549</article-id>
    <article-id pub-id-type="pmid">25189131</article-id>
    <article-id pub-id-type="publisher-id">6690</article-id>
    <article-id pub-id-type="doi">10.1186/1471-2105-15-297</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Enhancing protein-vitamin binding residues prediction by multiple heterogeneous subspace SVMs ensemble</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Yu</surname>
          <given-names>Dong-Jun</given-names>
        </name>
        <address>
          <email>njyudj@njust.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff58"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hu</surname>
          <given-names>Jun</given-names>
        </name>
        <address>
          <email>junh_cs@126.com</email>
        </address>
        <xref ref-type="aff" rid="Aff58"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yan</surname>
          <given-names>Hui</given-names>
        </name>
        <address>
          <email>yanhui@njust.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff58"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Xi-Bei</given-names>
        </name>
        <address>
          <email>yangxibei@hotmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff58"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Jing-Yu</given-names>
        </name>
        <address>
          <email>yangjy@njust.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff58"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Shen</surname>
          <given-names>Hong-Bin</given-names>
        </name>
        <address>
          <email>hbshen@sjtu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff59"/>
      </contrib>
      <aff id="Aff58"><label/>School of Computer Science and Engineering, Nanjing University of Science and Technology, Xiaolingwei 200, Nanjing, 210094 China </aff>
      <aff id="Aff59"><label/>Institute of Image Processing and Pattern Recognition, Shanghai Jiao Tong University, Dongchuan Road 800, Shanghai, 200240 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>5</day>
      <month>9</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>5</day>
      <month>9</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2014</year>
    </pub-date>
    <volume>15</volume>
    <issue>1</issue>
    <elocation-id>297</elocation-id>
    <history>
      <date date-type="received">
        <day>23</day>
        <month>3</month>
        <year>2014</year>
      </date>
      <date date-type="accepted">
        <day>18</day>
        <month>8</month>
        <year>2014</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© Yu et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
      <license license-type="open-access">
        <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p>Vitamins are typical ligands that play critical roles in various metabolic processes. The accurate identification of the vitamin-binding residues solely based on a protein sequence is of significant importance for the functional annotation of proteins, especially in the post-genomic era, when large volumes of protein sequences are accumulating quickly without being functionally annotated.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p>In this paper, a new predictor called TargetVita is designed and implemented for predicting protein-vitamin binding residues using protein sequences. In TargetVita, features derived from the position-specific scoring matrix (PSSM), predicted protein secondary structure, and vitamin binding propensity are combined to form the original feature space; then, several feature subspaces are selected by performing different feature selection methods. Finally, based on the selected feature subspaces, heterogeneous SVMs are trained and then ensembled for performing prediction.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p>The experimental results obtained with four separate vitamin-binding benchmark datasets demonstrate that the proposed TargetVita is superior to the state-of-the-art vitamin-specific predictor, and an average improvement of 10% in terms of the Matthews correlation coefficient (MCC) was achieved over independent validation tests. The TargetVita web server and the datasets used are freely available for academic use at <ext-link ext-link-type="uri" xlink:href="http://csbio.njust.edu.cn/bioinf/TargetVita">http://csbio.njust.edu.cn/bioinf/TargetVita</ext-link> or <ext-link ext-link-type="uri" xlink:href="http://www.csbio.sjtu.edu.cn/bioinf/TargetVita">http://www.csbio.sjtu.edu.cn/bioinf/TargetVita</ext-link>.</p>
      </sec>
      <sec>
        <title>Electronic supplementary material</title>
        <p>The online version of this article (doi:10.1186/1471-2105-15-297) contains supplementary material, which is available to authorized users.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Protein-vitamin binding residue</kwd>
      <kwd>Feature subspace</kwd>
      <kwd>Heterogeneous SVM</kwd>
      <kwd>Classifier ensemble</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2014</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p>Functional positions in a protein are residues that play more critical roles than other residues and enable the protein to perform specific biological functions, such as capturing drugs [<xref ref-type="bibr" rid="CR1">1</xref>], binding ligands [<xref ref-type="bibr" rid="CR2">2</xref>], and interacting with other proteins [<xref ref-type="bibr" rid="CR3">3</xref>]. However, functionally annotated proteins still account for only a small portion of sequenced proteins, and the gap between annotated and sequenced proteins is ever-increasing with the rapid development of advanced sequencing technology and concerted genome projects [<xref ref-type="bibr" rid="CR4">4</xref>]. Automated computational methods for the prediction of protein functional positions are urgently needed and have become a hotspot in bioinformatics research. During the past decades, machine-learning-based computational methods have been extensively applied to various protein functional position prediction problems [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref>].</p>
    <p>Protein-ligand interaction is one of the most important protein functions and plays vital roles in virtually all biological processes [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Considerable effort has been made to design effective methods for protein-ligand binding residue (site) prediction, and much progress has been made in this area [<xref ref-type="bibr" rid="CR10">10</xref>]. In the early stage, <italic>general-purpose</italic> protein-ligand predictors, which predict ligand binding sites (pockets) regardless of ligand types, dominate in the fields of protein-ligand binding site prediction. Such predictors include LIGSITE [<xref ref-type="bibr" rid="CR11">11</xref>], CASTp [<xref ref-type="bibr" rid="CR12">12</xref>], SURFNET [<xref ref-type="bibr" rid="CR13">13</xref>], POCKET [<xref ref-type="bibr" rid="CR14">14</xref>], fpocket [<xref ref-type="bibr" rid="CR15">15</xref>], Q-SiteFinder [<xref ref-type="bibr" rid="CR16">16</xref>], and SITEHOUND [<xref ref-type="bibr" rid="CR17">17</xref>]. Later, researchers observed that protein-ligand binding sites (pockets) vary significantly in their roles, sizes, and distributions for different types of protein-ligand interactions, and different ligands tend to bind diverse types of residues with prominent specificities [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. These observations motivated the emergence of <italic>ligand-specific</italic> predictors, which are specifically designed to predict binding residues or sites for certain ligand types, such as NsitePred [<xref ref-type="bibr" rid="CR20">20</xref>] and TargetS [<xref ref-type="bibr" rid="CR21">21</xref>] for protein-nucleotide binding prediction, FINDSITE-metal [<xref ref-type="bibr" rid="CR22">22</xref>] and CHED [<xref ref-type="bibr" rid="CR23">23</xref>] for protein-metal binding prediction, MetaDBSite [<xref ref-type="bibr" rid="CR24">24</xref>] and DNABR [<xref ref-type="bibr" rid="CR25">25</xref>] for protein-DNA binding prediction, protein-drug binding prediction [<xref ref-type="bibr" rid="CR26">26</xref>], and others. These studies have shown that <italic>ligand-specific</italic> predictors are often superior to <italic>general-purpose</italic> predictors and are a promising route for improving the performance of protein-ligand prediction [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p>
    <p>Vitamins are typical ligands and play critical roles in various metabolic processes [<xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR29">29</xref>]. However, to the best of our knowledge, minimal work has been performed to design a specific predictor for predicting protein-vitamin binding residues. Recently, Panwar et al. [<xref ref-type="bibr" rid="CR30">30</xref>] published their pioneering work on protein-vitamin binding prediction and a predictor, called VitaPred, was implemented. VitaPred [<xref ref-type="bibr" rid="CR30">30</xref>] is a sequence-based <italic>ligand-specific</italic> predictor specifically designed for predicting protein-vitamin binding residues, and it consists of four independent prediction modules for predicting vitamin, vitamin-A, vitamin-B, and pyridoxal-5-phosphate (vitamin-B6) binding residues. VitaPred encodes each residue into a 340-D feature vector by applying a sliding window to the position-specific scoring matrix (PSSM) of a protein sequence; then, a support vector machine (SVM) is trained on the set of feature vectors of all the training residues. In the prediction stage, the feature vector of each residue in a query sequence is fed into the trained SVM, and the binding propensity of each residue is obtained; finally, a threshold is used to determine whether a residue is vitamin-interacting. Although VitaPred achieved great success in predicting protein-vitamin binding residues, there is still room for further improving the prediction performance: first, only the PSSM-derived feature was used in VitaPred, and other valuable features (e.g., protein secondary structure) were not well considered; second, the PSSM feature constructed in VitaPred may contain redundant information, which is useless or even harmful for performing prediction.</p>
    <p>This paper follows the pioneering work of Panwar et al. [<xref ref-type="bibr" rid="CR30">30</xref>] and aims to further improve the performance of protein-vitamin binding residue prediction. A new predictor, called TargetVita, which utilises multiple sequence-derived features and heterogeneous SVMs ensemble based on feature selection, is developed. In TargetVita, three different types of features (i.e., a position-specific scoring matrix feature, a predicted secondary structure feature, and a vitamin binding propensity feature) are combined to form the original feature space; then, three feature selection methods are performed on the original feature space to extract three different feature subspaces, and heterogeneous SVMs are trained on the reduced feature subspaces. Finally, when performing prediction, the vitamin-binding propensity of each residue in a query sequence is predicted by averaging the outputs of the three trained heterogeneous SVMs. Experimental results obtained with four separate vitamin-binding benchmark datasets demonstrate that the proposed TargetVita is superior to VitaPred [<xref ref-type="bibr" rid="CR30">30</xref>] and an average improvement of 10% in terms of the Matthews correlation coefficient (<italic>MCC</italic>) was achieved over independent validation tests.</p>
  </sec>
  <sec id="Sec2" sec-type="methods">
    <title>Methods</title>
    <sec id="Sec3">
      <title>Benchmark datasets</title>
      <p>In this study, four benchmark datasets created by Panwar et al. [<xref ref-type="bibr" rid="CR30">30</xref>] were utilised to evaluate the efficacy of the proposed method. For convenience, the four benchmark datasets are denoted as DVI (dataset of vitamin-interacting proteins), DVAI (dataset of vitamin-A-interacting proteins), DVBI (dataset of vitamin-B-interacting proteins), and DPLPI (dataset of pyridoxal-5-phosphate interacting proteins), respectively.</p>
      <p>Each benchmark dataset was constructed with a stringent procedure as follows [<xref ref-type="bibr" rid="CR30">30</xref>]: taking DVI as an example, 1061 PDB IDs of proteins that make contact with vitamins were first collected from SuperSite documentation [<xref ref-type="bibr" rid="CR31">31</xref>]; then, the sequences of all chains of these 1061 PDB IDs were downloaded from the Protein Data Bank [<xref ref-type="bibr" rid="CR32">32</xref>]. Among the obtained sequences, 2720 sequences were finally chosen according to the results returned from the Ligand Protein Contact (LPC) web server [<xref ref-type="bibr" rid="CR33">33</xref>] by taking 1061 PDB IDs as inputs. Then, a threshold of 5.0 Å was used to determine the vitamin-interacting residues: a residue was considered to be vitamin-interacting if the closest distance between atoms of the protein and the partner vitamin was within the threshold (5.0 Å) [<xref ref-type="bibr" rid="CR30">30</xref>]; finally, the maximal pairwise sequence identity of the vitamin-binding sequences obtained in the above steps was further reduced to 25% by using BLASTCLUST [<xref ref-type="bibr" rid="CR34">34</xref>], and the obtained 187 vitamin-interacting chains with 30156 vitamin-binding residues constituted the DVI. Similarly, DVAI, DVBI, and DPLPI, which consist of 31, 141, and 71 non-redundant sequences, respectively, were also constructed by repeating the above-mentioned steps.</p>
      <p>Four different independent validation datasets for DVI, DVAI, DVBI, and DPLPI, which consist of 46, 15, 27, and 16 non-redundant sequences, respectively, were also constructed [<xref ref-type="bibr" rid="CR30">30</xref>]. In addition, to guarantee the independence of the independent validation subset, the maximal pairwise sequence identity of each independent validation dataset is less than 25%, and any sequence in an independent validation dataset shares &lt;25% identity to the sequences in the corresponding training dataset. Table <xref rid="Tab1" ref-type="table">1</xref> summarises the detailed compositions of the four benchmark datasets. Details for constructing these datasets can be found in [<xref ref-type="bibr" rid="CR30">30</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p><bold>Compositions of the training datasets and the corresponding independent validation datasets for the 4 types of vitamin-interacting benchmark datasets</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dataset</th><th colspan="2">Training Dataset</th><th colspan="2">Independent Validation Dataset</th><th>Total No. of Sequences</th></tr><tr><th/><th>No. of Sequences</th><th>(numP, numN)
<sup>*</sup>
</th><th>No. of Sequences</th><th>(numP, numN)
<sup>*</sup>
</th><th/></tr></thead><tbody><tr><td align="center">DVI</td><td align="center">187</td><td align="center">(3016, 62122)</td><td align="center">46</td><td align="center">(654, 11676)</td><td align="center">233</td></tr><tr><td align="center">DVAI</td><td align="center">31</td><td align="center">(538, 7376)</td><td align="center">15</td><td align="center">(181, 1441)</td><td align="center">46</td></tr><tr><td align="center">DVBI</td><td align="center">141</td><td align="center">(2219, 50179)</td><td align="center">27</td><td align="center">(419, 8947)</td><td align="center">168</td></tr><tr><td align="center">DPLPI</td><td align="center">71</td><td align="center">(1092, 26638)</td><td align="center">16</td><td align="center">(246, 5935)</td><td align="center">87</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>numP and numN represent the numbers of positive (binding) and negative (non-binding) samples, respectively.</p></table-wrap-foot></table-wrap></p>
      <p>To evaluate the performance of TargetVita with non-vitamin binding proteins, we also constructed a non-vitamin binding dataset, denoted as NVD, from BioLip [<xref ref-type="bibr" rid="CR35">35</xref>], which is the most recently released semi-manually curated database for biologically relevant ligand–protein interactions. We constructed the NVD as follows: First, all the sequences that do not interact with vitamins are extracted from BioLip; then, the maximal pairwise sequence identity of the extracted protein sequences is culled to 30% by using CD-Hit [<xref ref-type="bibr" rid="CR36">36</xref>] program, and the reduced dataset is obtained. Moreover, if a given sequence in the reduced dataset shares &gt;30% identity with a sequence in the training dataset DVI, we remove the sequence from the reduced dataset. Finally, the remaining 6676 sequences (with 1852390 residues) constitute NVD.</p>
      <p>All the datasets used in this study are included in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p>
    </sec>
    <sec id="Sec4">
      <title>Feature representation</title>
      <p>Feature representation is a critical step in designing a machine-learning-based predictor. In this study, multiple sequence-derived features, which potentially have a positive impact on the performance improvement of protein-vitamin binding residue prediction, are extracted and combined to form an informative feature space.</p>
      <sec id="Sec5">
        <title>1) Position-specific scoring matrix (PSSM)</title>
        <p>Previous studies have demonstrated that the evolutionary information reflected by a position specific scoring matrix (PSSM) is a powerful feature source in many bioinformatics problems including protein-ligand binding predictions [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR37">37</xref>–<xref ref-type="bibr" rid="CR40">40</xref>]. In view of this, PSSM was also taken as a feature source in this study. First, we obtained the original PSSM of a sequence by executing PSI-BLAST [<xref ref-type="bibr" rid="CR41">41</xref>] to search the Swiss-Prot database through three iterations with 0.001 as the <italic>E</italic>-value cut-off against the sequence; then, each element <italic>x</italic> contained in PSSM was normalised by the logistic function <italic>f</italic>(<italic>x</italic>) = 1/(1 + e<sup>− <italic>x</italic></sup>), and the normalised PSSM was obtained. Finally, the PSSM-based feature vector for each residue in the query sequence can be extracted with a sliding window as follows: for a residue at position <italic>i</italic> of the query sequence, its feature vector consists of the normalised PSSM elements of the query sequence corresponding to a sequence segment of length <italic>W</italic> centred on <italic>i</italic>. In this study, <italic>W</italic>, i.e., the size of sliding window, was set to 17, which has been demonstrated to be a better choice in VitaPred [<xref ref-type="bibr" rid="CR30">30</xref>] and several other protein-ligand binding site prediction studies [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Consequently, the dimensionality of the <italic>PSSM</italic> feature vector of a residue is 17 × 20 = 340.</p>
      </sec>
      <sec id="Sec6">
        <title>2) Predicted secondary structures (PSSs)</title>
        <p>A fundamental hypothesis for most of the sequence-based protein attribute predictions is that sequences with similar structures will have similar functions. Previous studies have also shown that a close relationship exists between protein structure and function. Many structural characteristics, such as secondary structure information, have been extensively investigated for the identification of protein functional residues (e.g., protein-ligand binding residues [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]). The appropriate utilisation of protein structural information may potentially help to improve the performance of protein-ligand binding prediction, as has been empirically demonstrated in our recent work [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Therefore, protein secondary structure information, predicted from the protein sequence by performing PSIPRED [<xref ref-type="bibr" rid="CR43">43</xref>], was used as another feature source for protein-vitamin binding residue prediction.</p>
        <p>The predicted secondary structure information of a protein sequence is obtained by applying PSIPRED [<xref ref-type="bibr" rid="CR43">43</xref>] software, which predicts the likelihood that a given residue in a protein sequence belongs to one of three secondary structure classes: coil (C), helix (H), and strand (E). More specifically, for a protein sequence with <italic>L</italic> residues, PSIPRED outputs an <italic>L</italic> × 3 probability matrix, which represents the predicted secondary structure information of the protein. Again, a sliding window of size 17 was used to extract the predicted secondary structure feature of each residue, and the dimensionality of the extracted <italic>PSSs</italic> feature vector was 17 × 3 = 51.</p>
      </sec>
      <sec id="Sec7">
        <title>3) Vitamin binding propensities (VBPs)</title>
        <p>Previous studies have demonstrated that different ligands tend to bind different residues [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Panwar et al. [<xref ref-type="bibr" rid="CR30">30</xref>] also analysed different protein-interacting residues of different vitamin classes and observed that different vitamins tend to bind different residues; this phenomenon can also be observed within vitamin sub-classes. Motivated by this observation, we can thus calculate the binding propensities of the 20 native amino acids for each type of vitamin and then extract a vitamin-specific 17-D binding propensity feature vector, denoted as <italic>VBP</italic>, for each residue in a protein sequence by concatenating the binding propensities of its neighbouring residues within a window of size 17 centred at the residue.</p>
        <p>Finally, the feature representation of a residue is formed by serially combining its three corresponding feature vectors, i.e., <italic>PSSM</italic>, <italic>PSSs</italic>, and <italic>VBPs</italic>, and the dimensionality of the obtained feature vector is 340 + 51 + 17 = 408-D.</p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Ensemble multiple heterogeneous subspace SVMs based on feature selection</title>
      <p>After determining the feature representation, prediction models can be trained on a dataset with machine-learning algorithms such as SVM, as used in this study. However, directly training prediction models on the original feature space is often not the best solution. One important reason is that redundant information that has no positive, and sometimes even negative, impact on the prediction performance could potentially exist. Selection of the most discriminative feature subspace from the original feature space may help to improve prediction performance. Accordingly, feature selection has been a hotspot and is widely used in many bioinformatics and related fields [<xref ref-type="bibr" rid="CR44">44</xref>], such as sequence analysis [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>] and microarray analysis [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. For example, our recent work [<xref ref-type="bibr" rid="CR49">49</xref>] has demonstrated that the <italic>PSSM</italic> feature contains redundant information, which is useless for disulphide connectivity prediction, and the prediction performance can be further improved when the original PSSM feature is reduced to a lower but more compact feature subspace via feature selection.</p>
      <p>However, many existing traditional feature selection methods such as data variance [<xref ref-type="bibr" rid="CR49">49</xref>], the Fisher score [<xref ref-type="bibr" rid="CR50">50</xref>], and the Laplacian score [<xref ref-type="bibr" rid="CR51">51</xref>] are faced with two deficiencies: first, the importance of features is calculated individually; thus, the correlation and dependency of different feature components are neglected. Second, the dimensionality of the reduced feature subspace needs to be prescribed in advance of the feature selection process, which is often difficult or even impossible in practice.</p>
      <p>Recently, we developed a generalised Joint Laplacian Feature Weights Learning algorithm [<xref ref-type="bibr" rid="CR52">52</xref>], denoted as JLFWL, which can effectively address the above-mentioned two deficiencies. Rather than computing feature weights one by one, JLFWL automatically determines the optimal size of the feature subspace and selects the best feature components from the original feature space by iteratively learning the feature weights jointly and simultaneously.</p>
      <p>Here, we briefly restate JLFWL; details can be found in [<xref ref-type="bibr" rid="CR52">52</xref>].</p>
      <p>Let matrix <italic>X</italic> = [<bold>x</bold><sub>1</sub>, <bold>x</bold><sub>2</sub>, ⋯, <bold>x</bold><sub><italic>M</italic></sub>] ∈ <italic>R</italic><sup><italic>N</italic> × <italic>M</italic></sup> be a training dataset, where <italic>M</italic> is the number of samples, <italic>N</italic> is the dimensionality of features, and <bold>x</bold><sub><italic>i</italic></sub> is the feature vector of the <italic>i</italic>-th training sample. Then, the Joint Laplacian Feature Weights Learning can be summarised in Algorithm 1.
<disp-formula id="Equa"><graphic xlink:href="12859_2014_6690_Equa_HTML.gif" position="anchor"/></disp-formula></p>
      <p>Note that in Algorithm 1, <italic>ε</italic> ≥ 0 is a parameter to control the <inline-formula id="IEq1"><inline-graphic xlink:href="12859_2014_6690_IEq1_HTML.gif"/></inline-formula> -norm of <bold>w</bold>. In this study, <italic>ε</italic> is set to be 0.5.</p>
      <p>Different feature subspaces can be selected from the original feature space with different feature selection methods, and the discriminative characteristics of the obtained feature subspaces may also differ. Prediction models trained on these different feature subspaces potentially complement each other, which motivates us to propose an ensemble learning scheme, i.e., a multiple heterogeneous subspace SVMs ensemble based on feature selection, as follows:</p>
      <p>First, multiple feature subspaces are selected by applying different feature selection methods; then, based on these selected feature subspaces, multiple prediction models, which are termed as heterogeneous models, can be trained on the same dataset; for a query input, the final prediction output is obtained by ensembling the outputs of the trained heterogeneous prediction models.</p>
      <p>To demonstrate the efficacy of the proposed ensemble learning scheme, three feature selection methods (i.e., our JLFWL together with two traditional feature selection methods, such as the Fisher score [<xref ref-type="bibr" rid="CR50">50</xref>] and Laplacian score [<xref ref-type="bibr" rid="CR51">51</xref>]) are taken to perform feature selections, and SVM [<xref ref-type="bibr" rid="CR53">53</xref>][<xref ref-type="bibr" rid="CR54">54</xref>] is used as the base machine-learning algorithm to train multiple heterogeneous prediction models. We locally performed JLFWL on benchmark datasets and found that the optimal dimensionality of the feature subspace, which is automatically determined by JLFWL, is 386. For consistency, the dimensionalities of the feature subspaces obtained by Fisher score [<xref ref-type="bibr" rid="CR50">50</xref>] and Laplacian score [<xref ref-type="bibr" rid="CR51">51</xref>] feature selection methods are also set to be 386.</p>
      <p>In this study, C-SVM is used and there are no specific weights for the three heterogamous SVM models. Radial basis function is chosen as the kernel function. The other two parameters, i.e., the regularisation parameter <italic>γ</italic> and the kernel width parameter <italic>σ</italic>, are set according to the optimisation results from a grid search strategy in the LIBSVM software.</p>
    </sec>
    <sec id="Sec9">
      <title>Workflow of the proposed TargetVita</title>
      <p>Figure <xref rid="Fig1" ref-type="fig">1</xref> illustrates the workflow of the proposed TargetVita. In the training stage, all the feature vectors of the residues in the training sequences constitute the training feature vector set; then, <italic>L</italic> feature subspaces can be selected by performing <italic>L</italic> different feature selection methods on the training feature vector set; based on the selected feature subspace, <italic>L</italic> heterogamous SVM models can be trained.<fig id="Fig1"><label>Figure 1</label><caption><p><bold>Workflow of the proposed TargetVita.</bold> Predicted binding residues, modelled 3D structure, and the vitamin are highlighted in red, green, and yellow colours, respectively. Arrows highlighted in blue colour denote the workflows in the training stage, while arrows in black colour denote the workflows in the prediction stage.</p></caption><graphic xlink:href="12859_2014_6690_Fig1_HTML" id="d30e909"/></fig></p>
      <p>In the prediction stage, for each residue in a query protein sequence, its <italic>PSSM</italic> and <italic>PSSs</italic> feature vectors are first extracted by calling PSI-BLAST and PSIPRED and applying a sliding window technique; then, its <italic>PSSM</italic>, <italic>PSSs</italic>, and <italic>VBP</italic> feature vectors are combined and filtered by the <italic>L</italic> selected feature subspaces, and the <italic>L</italic> filtered feature vectors (i.e., feature vectors after feature selection) are further fed to the <italic>L</italic> corresponding trained heterogamous SVMs that predict, for that residue, the scores related to vitamin interaction; the final score for the residue is obtained by averaging the predicted scores of those heterogeneous SVM models. Finally, a threshold <italic>T</italic> is used to determine whether the residue is vitamin-interacting: residues with scores above threshold are marked as vitamin-interacting.</p>
      <p>To help with the visualisation of the prediction results, MODELLER software [<xref ref-type="bibr" rid="CR55">55</xref>] is taken to model the protein 3D structure from the sequence, and the predicted vitamin-interacting residues are highlighted in red on the modelled 3D structure.</p>
    </sec>
    <sec id="Sec10">
      <title>Evaluation indexes</title>
      <p>To evaluate the performance of the proposed method, four routinely used evaluation indexes in this field, i.e., <italic>Sensitivity</italic> (<italic>Sn</italic>), <italic>Specificity</italic> (<italic>Sp</italic>), <italic>Accuracy</italic> (<italic>Acc</italic>), and the Matthews correlation coefficient (<italic>MCC</italic>) were taken:
<disp-formula id="Equ1"><label>1</label><graphic xlink:href="12859_2014_6690_Equ1_HTML.gif" position="anchor"/></disp-formula><disp-formula id="Equ2"><label>2</label><graphic xlink:href="12859_2014_6690_Equ2_HTML.gif" position="anchor"/></disp-formula><disp-formula id="Equ3"><label>3</label><graphic xlink:href="12859_2014_6690_Equ3_HTML.gif" position="anchor"/></disp-formula><disp-formula id="Equ4"><label>4</label><graphic xlink:href="12859_2014_6690_Equ4_HTML.gif" position="anchor"/></disp-formula></p>
      <p>where <italic>TP</italic>, <italic>FP</italic>, <italic>TN</italic>, and <italic>FN</italic> are the abbreviations of True Positive, False Positive, True Negative, and False Negative, respectively.</p>
      <p>However, these four evaluation indexes are threshold-dependent, i.e., the values of these indexes vary with the threshold chosen. Clearly, it is impossible and unnecessary to report the values of these indexes under all the possible thresholds [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. In light of this, two threshold selection strategies, which have been widely applied in the related fields, were taken to report the threshold-dependent evaluation indexes, i.e., <italic>Sn</italic>, <italic>Sp</italic>, <italic>Acc</italic>, and <italic>MCC</italic>.</p>
      <p><bold>Strategy I:</bold> Threshold that balances the values of <italic>Sn</italic> and <italic>Sp</italic></p>
      <p>The threshold-dependent evaluation indexes are reported with a threshold, denoted as <italic>T</italic><sub><italic>Balance</italic></sub>, at which the value of <italic>Sn</italic> is equal or roughly equal to that of <italic>Sp</italic>. For convenience, the evaluation results obtained under <italic>T</italic><sub><italic>Balance</italic></sub> will be termed as <italic>Balanced Evaluation</italic> in the subsequent descriptions.</p>
      <p><bold>Strategy II:</bold> Threshold that maximises the value of <italic>MCC</italic></p>
      <p>Because the <italic>MCC</italic> provides the overall measurement of the quality of the binary predictions, we thus reported the threshold-dependent evaluation indexes by choosing the threshold, denoted as <italic>T</italic><sub><italic>MaxMCC</italic></sub>, which maximises the value of <italic>MCC</italic> of predictions. Similarly, for convenience, the evaluation results obtained under <italic>T</italic><sub><italic>MaxMCC</italic></sub> will be termed as <italic>MaxMCC Evaluation</italic>.</p>
      <p>In addition, to evaluate the overall prediction quality of a prediction model, the <italic>AUC</italic>, which is the area under the Receiver Operating Characteristic (<italic>ROC</italic>) curve and is threshold-independent, was also taken.</p>
    </sec>
  </sec>
  <sec id="Sec11">
    <title>Results and discussion</title>
    <sec id="Sec12">
      <title>Inappropriate cross-validation will over-estimate prediction performance</title>
      <p>Cross-validation methods are often used to evaluate the performance of a predictor [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Previous studies have shown that the leave-one-out cross-validation (jack-knife test) is most stringent [<xref ref-type="bibr" rid="CR58">58</xref>–<xref ref-type="bibr" rid="CR61">61</xref>]. However, leave-one-out cross-validation is time-consuming, especially when a dataset is huge and a complicated prediction algorithm (such as SVM in this study) is used. Additionally, because we need make a fair comparison of the proposed method with VitaPred [<xref ref-type="bibr" rid="CR30">30</xref>], the five-fold cross-validation, which was used by Panwar et al. [<xref ref-type="bibr" rid="CR30">30</xref>] to evaluate VitaPred, was also adopted in this study.</p>
      <p>Another critical aspect that should be addressed here is the method of performing five-fold cross-validation. In fact, five-fold cross-validation can be performed at two different levels for the considered protein-vitamin binding residue prediction problem: (i) residue-level cross-validation and (ii) sequence-level cross-validation.</p>
      <p>Residue-level five-fold cross-validation is performed as follows: residues in all the training protein sequences are randomly partitioned into five equally sized, disjoint subsets; then, one subset is used for testing, and the remaining four subsets are used for training; this process is continued until all the five subsets of the training dataset are traversed.</p>
      <p>For sequence-level five-fold cross-validation, training protein sequences, rather than training residues, are randomly partitioned into five equally sized, disjoint subsets; then, residues in one subset are used for testing, and residues in the remaining four subsets are used for training; this practice is continued until all the five subsets of the training dataset are traversed.</p>
      <p>In reference [<xref ref-type="bibr" rid="CR30">30</xref>], Panwar et al. used residue-level cross-validation to evaluate the performance of their VitaPred. However, we believe that residue-level cross-validation tends to over-estimate the performance of a prediction model and is therefore inappropriate. Next, we will empirically demonstrate this argument as follows:</p>
      <p>Note that to objectively and fairly compare our results with those obtained by VitaPred [<xref ref-type="bibr" rid="CR30">30</xref>], the same machine-learning model (i.e., SVM) and the same feature representation (i.e., 340-D PSSM feature) were also used in our experiments.</p>
      <p>For each of the four benchmark datasets (i.e., DVI, DVAI, DVBI, and DPLPI), we performed residue- and sequence-level five-fold cross-validations. Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref> summarise the performance comparisons between residue- and sequence-level five-fold cross-validations on the four benchmark datasets under <italic>Balanced Evaluation</italic> and <italic>MaxMCC Evaluation</italic>, respectively. Note that in Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>, SVM-R and SVM-S denote the results obtained by residue- and sequence-level cross-validations, respectively.<table-wrap id="Tab2"><label>Table 2</label><caption><p><bold>Performance comparisons between residue- and sequence-level five-fold cross-validations on DVI, DVAI, DVBI, and DPLPI under</bold><bold><italic>Balanced Evaluation</italic></bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dataset</th><th>Method</th><th><italic>Sn</italic>
(%)</th><th><italic>Sp</italic>
(%)</th><th><italic>Acc</italic>
(%)</th><th><italic>MCC</italic></th><th><italic>AUC</italic></th><th><italic>TP</italic></th><th><italic>TN</italic></th><th><italic>FP</italic></th><th><italic>FN</italic></th></tr></thead><tbody><tr><td align="center" rowspan="3">DVI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">78.52</td><td align="center">78.61</td><td align="center">78.60</td><td align="center">0.37</td><td align="center">0.87</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-R<sup>◇</sup>
</td><td align="center">77.88</td><td align="center">81.34</td><td align="center">81.18</td><td align="center">0.30</td><td align="center">0.87</td><td align="center">2349</td><td align="center">50530</td><td align="center">11592</td><td align="center">667</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">77.65</td><td align="center">80.16</td><td align="center">80.04</td><td align="center">0.29</td><td align="center">0.87</td><td align="center">2342</td><td align="center">49797</td><td align="center">12325</td><td align="center">674</td></tr><tr><td align="center" rowspan="3">DVAI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">72.70</td><td align="center">76.89</td><td align="center">76.51</td><td align="center">0.32</td><td align="center">0.83</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-R<sup>◇</sup>
</td><td align="center">73.98</td><td align="center">77.94</td><td align="center">77.67</td><td align="center">0.30</td><td align="center">0.85</td><td align="center">398</td><td align="center">5749</td><td align="center">1627</td><td align="center">140</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">72.12</td><td align="center">76.34</td><td align="center">76.06</td><td align="center">0.28</td><td align="center">0.82</td><td align="center">388</td><td align="center">5631</td><td align="center">1745</td><td align="center">150</td></tr><tr><td align="center" rowspan="3">DVBI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">83.33</td><td align="center">80.51</td><td align="center">80.77</td><td align="center">0.42</td><td align="center">0.90</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-R<sup>◇</sup>
</td><td align="center">80.44</td><td align="center">83.83</td><td align="center">83.68</td><td align="center">0.33</td><td align="center">0.90</td><td align="center">1785</td><td align="center">42063</td><td align="center">8116</td><td align="center">434</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">79.86</td><td align="center">82.90</td><td align="center">82.77</td><td align="center">0.32</td><td align="center">0.89</td><td align="center">1772</td><td align="center">41598</td><td align="center">8581</td><td align="center">447</td></tr><tr><td align="center" rowspan="3">DPLPI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">90.20</td><td align="center">92.61</td><td align="center">92.40</td><td align="center">0.67</td><td align="center">0.97</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-R<sup>◇</sup>
</td><td align="center">91.48</td><td align="center">93.38</td><td align="center">93.30</td><td align="center">0.55</td><td align="center">0.97</td><td align="center">999</td><td align="center">24874</td><td align="center">1764</td><td align="center">93</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">90.38</td><td align="center">92.62</td><td align="center">92.53</td><td align="center">0.52</td><td align="center">0.96</td><td align="center">987</td><td align="center">24672</td><td align="center">1966</td><td align="center">105</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>Data obtained from [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p><sup>◇</sup>SVM-R: The re-implementation of VitaPred over residue-level cross-validation.</p><p><sup>△</sup>SVM-S: The re-implementation of VitaPred over sequence-level cross-validation.</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p><bold>Performance comparisons between residue- and sequence-level five-fold cross-validations on DVI, DVAI, DVBI, and DPLPI under</bold><bold><italic>MaxMCC Evaluation</italic></bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dataset</th><th>Method</th><th><italic>Sn</italic>
(%)</th><th><italic>Sp</italic>
(%)</th><th><italic>Acc</italic>
(%)</th><th><italic>MCC</italic></th><th><italic>AUC</italic></th><th><italic>TP</italic></th><th><italic>TN</italic></th><th><italic>FP</italic></th><th><italic>FN</italic></th></tr></thead><tbody><tr><td align="center" rowspan="3">DVI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">52.19</td><td align="center">96.79</td><td align="center">92.73</td><td align="center">0.53</td><td align="center">0.87</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-R<sup>◇</sup>
</td><td align="center">52.62</td><td align="center">98.29</td><td align="center">96.18</td><td align="center">0.54</td><td align="center">0.87</td><td align="center">1586</td><td align="center">61063</td><td align="center">1059</td><td align="center">1430</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">52.29</td><td align="center">98.32</td><td align="center">96.19</td><td align="center">0.54</td><td align="center">0.87</td><td align="center">1577</td><td align="center">61076</td><td align="center">1046</td><td align="center">1439</td></tr><tr><td align="center" rowspan="3">DVAI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">42.75</td><td align="center">97.51</td><td align="center">92.54</td><td align="center">0.48</td><td align="center">0.83</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-R<sup>◇</sup>
</td><td align="center">43.49</td><td align="center">96.39</td><td align="center">92.80</td><td align="center">0.41</td><td align="center">0.85</td><td align="center">234</td><td align="center">7110</td><td align="center">266</td><td align="center">304</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">40.15</td><td align="center">96.39</td><td align="center">92.57</td><td align="center">0.39</td><td align="center">0.82</td><td align="center">216</td><td align="center">7109</td><td align="center">267</td><td align="center">322</td></tr><tr><td align="center" rowspan="3">DVBI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">55.57</td><td align="center">98.04</td><td align="center">94.18</td><td align="center">0.61</td><td align="center">0.90</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-R<sup>◇</sup>
</td><td align="center">58.77</td><td align="center">98.45</td><td align="center">96.77</td><td align="center">0.59</td><td align="center">0.90</td><td align="center">1304</td><td align="center">49401</td><td align="center">778</td><td align="center">915</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">58.18</td><td align="center">98.40</td><td align="center">96.69</td><td align="center">0.58</td><td align="center">0.89</td><td align="center">1291</td><td align="center">49373</td><td align="center">806</td><td align="center">928</td></tr><tr><td align="center" rowspan="3">DPLPI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">79.76</td><td align="center">98.62</td><td align="center">96.91</td><td align="center">0.81</td><td align="center">0.97</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-R<sup>◇</sup>
</td><td align="center">79.67</td><td align="center">99.19</td><td align="center">98.42</td><td align="center">0.79</td><td align="center">0.97</td><td align="center">870</td><td align="center">26422</td><td align="center">216</td><td align="center">222</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">80.86</td><td align="center">99.07</td><td align="center">98.36</td><td align="center">0.79</td><td align="center">0.96</td><td align="center">883</td><td align="center">26391</td><td align="center">247</td><td align="center">209</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>Data excerpted from [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p><sup>◇</sup>SVM-R: The re-implementation of VitaPred over residue-level cross-validation.</p><p><sup>△</sup>SVM-S: The re-implementation of VitaPred over sequence-level cross-validation.</p></table-wrap-foot></table-wrap></p>
      <p>In Table <xref rid="Tab2" ref-type="table">2</xref>, it can be observed that the values of <italic>Sn</italic>, <italic>Sp</italic>, <italic>Acc</italic>, <italic>MCC</italic>, and <italic>AUC</italic> for SVM-R are consistently superior to those for SVM-S throughout the four benchmark datasets. Taking <italic>MCC</italic> as an example, SVM-R clearly outperforms SVM-S, and an average improvement of 2% was observed on the four benchmark datasets. Similar results can also be observed in Table <xref rid="Tab3" ref-type="table">3</xref>. From the comparison results between SVM-R and SVM-S on the four considered datasets listed in Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>, we empirically demonstrated that the residue-level cross-validation does over-estimate the performance of a prediction model. We speculate that the main reason for this over-estimation is that during the residue-level cross-validation, some testing residues and training residues may originate from the same protein sequence and thus have much higher homology, which will lead to a better prediction performance.</p>
      <p>On the other hand, SVM-R is in fact a re-implementation of VitaPred [<xref ref-type="bibr" rid="CR30">30</xref>] because the prediction model and feature representation used in SVM-R are exactly the same as those used in VitaPred. By revisiting Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>, we can find that the <italic>AUC</italic> values for SVM-R on the four benchmark datasets are 0.87, 0.85, 0.90, and 0.97, which are equal to that for VitaPred with only one minor exception (i.e., 0.85 and 0.83 for SVM-R and VitaPred, respectively, in the DVAI dataset), showing that SVM-R and VitaPred achieved almost equal overall prediction quality.</p>
      <p>However, several abnormal phenomena are observed when comparing the other four indexes, (i.e., <italic>Sn</italic>, <italic>Sp</italic>, <italic>Acc</italic>, and <italic>MCC</italic>) between SVM-R and VitaPred. Using the results in the DPLPI dataset under Balanced Evaluation as an example (refer to Table <xref rid="Tab2" ref-type="table">2</xref>), the values of <italic>Sn</italic>, <italic>Sp</italic>, and <italic>Acc</italic> for VitaPred are 90.20%, 92.61%, and 92.40%, respectively, which are obviously lower than those for SVM-R (i.e., 91.48%, 93.38%, and 93.30%, respectively); however, the value of <italic>MCC</italic> for VitaPred is, unexpectedly, approximately 12% higher than that for SVM-R. A similar phenomenon can also be observed in the DVAI dataset. According to the definitions of <italic>Sn</italic>, <italic>Sp</italic>, <italic>Acc</italic>, and <italic>MCC</italic> and the relationships between them, this phenomenon should not appear. Based on the comparison between SVM-R and VitaPred, we speculate that the <italic>MCC</italic> reported in VitaPred [<xref ref-type="bibr" rid="CR30">30</xref>] has been over-estimated or over-optimised, which will be further demonstrated in the subsequent independent validation test.</p>
      <p>Considering that the residue-level cross-validation will over-estimate the performance of a prediction model, together with the fact that VitaPred may possibly have over-estimated the <italic>MCC</italic>s on benchmark datasets, we will take SVM-S (i.e., a re-implementation of VitaPred) over sequence-level cross-validation evaluation, rather than VitaPred itself, as the baseline predictor to demonstrate the improvements in our proposed methods in the subsequent experiments.</p>
    </sec>
    <sec id="Sec13">
      <title>Improving prediction performance by combining the features of <italic>PSSM</italic>, <italic>PSSs</italic>, and <italic>VBPs</italic></title>
      <p>In this section, we will demonstrate that the performance of protein-vitamin interaction prediction can be further improved by combining the features of <italic>PSSM</italic>, <italic>PSSs</italic>, and <italic>VBPs</italic>. The features of 340-D <italic>PSSM</italic>, 51-D <italic>PSSs</italic>, and 17-D <italic>VBPs</italic> are serially combined to form a 408-D discriminative feature, denoted as <italic>PSSM</italic> + <italic>PSSs</italic> + <italic>VBPs</italic>. We then evaluated the SVM-S with the <italic>PSSM</italic> + <italic>PSSs</italic> + <italic>VBPs</italic> feature as a model input on each of the four benchmark datasets over five-fold sequence-level cross-validation. Tables <xref rid="Tab4" ref-type="table">4</xref> and <xref rid="Tab5" ref-type="table">5</xref> summarise the performance comparisons between the <italic>PSSM</italic> + <italic>PSSs + VBPs</italic> and <italic>PSSM</italic> features under <italic>Balanced Evaluation</italic> and <italic>MaxMCC Evaluation</italic>, respectively. From Tables <xref rid="Tab4" ref-type="table">4</xref> and <xref rid="Tab5" ref-type="table">5</xref>, we can see that the prediction performances are indeed improved on all the four benchmark datasets after incorporating <italic>PSSs</italic> and <italic>VBPs</italic> features into the <italic>PSSM</italic> feature under both <italic>Balanced Evaluation</italic> and <italic>MaxMCC Evaluation</italic>. Taking <italic>MCC</italic>, which is the overall measurement of the quality of the binary predictions, as an example, an average improvement of 1.5% was observed under both <italic>Balanced Evaluation</italic> and <italic>MaxMCC Evaluation</italic>. In terms of the <italic>AUC</italic>, which measures the overall prediction quality of a prediction mode, an average improvement of 1% was also observed. Figure <xref rid="Fig2" ref-type="fig">2</xref> illustrates the ROC curves of the predictions with <italic>PSSM</italic> and <italic>PSSM</italic> + <italic>PSSs</italic> + <italic>VBPs</italic> features, respectively, on the DVI dataset over sequence-level five-fold cross-validation.<table-wrap id="Tab4"><label>Table 4</label><caption><p><bold>Performance comparisons between</bold><bold><italic>PSSM + PSSs</italic></bold> <bold>+</bold> <bold><italic>VBPs</italic></bold><bold>and</bold><bold><italic>PSSM</italic></bold><bold>features on DVI, DVAI, DVBI, and DPLPI datasets over five-fold sequence-level cross-validation under</bold><bold><italic>Balanced Evaluation</italic></bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dataset</th><th>Feature</th><th><italic>Sn</italic>
(%)</th><th><italic>Sp</italic>
(%)</th><th><italic>Acc</italic>
(%)</th><th><italic>MCC</italic></th><th><italic>AUC</italic></th><th><italic>TP</italic></th><th><italic>TN</italic></th><th><italic>FP</italic></th><th><italic>FN</italic></th></tr></thead><tbody><tr><td align="center" rowspan="2">DVI</td><td align="center"><italic>PSSM</italic></td><td align="center">77.65</td><td align="center">80.16</td><td align="center">80.04</td><td align="center">0.29</td><td align="center">0.87</td><td align="center">2342</td><td align="center">49797</td><td align="center">12325</td><td align="center">674</td></tr><tr><td align="center"><italic>PSSM</italic> + <italic>PSSs + VBPs</italic></td><td align="center">78.55</td><td align="center">82.02</td><td align="center">81.86</td><td align="center">0.31</td><td align="center">0.88</td><td align="center">2369</td><td align="center">50951</td><td align="center">11171</td><td align="center">647</td></tr><tr><td align="center" rowspan="2">DVAI</td><td align="center"><italic>PSSM</italic></td><td align="center">72.12</td><td align="center">76.34</td><td align="center">76.06</td><td align="center">0.28</td><td align="center">0.82</td><td align="center">388</td><td align="center">5631</td><td align="center">1745</td><td align="center">150</td></tr><tr><td align="center"><italic>PSSM</italic> + <italic>PSSs + VBPs</italic></td><td align="center">72.12</td><td align="center">78.28</td><td align="center">77.86</td><td align="center">0.29</td><td align="center">0.84</td><td align="center">388</td><td align="center">5774</td><td align="center">1602</td><td align="center">150</td></tr><tr><td align="center" rowspan="2">DVBI</td><td align="center"><italic>PSSM</italic></td><td align="center">79.86</td><td align="center">82.90</td><td align="center">82.77</td><td align="center">0.32</td><td align="center">0.89</td><td align="center">1772</td><td align="center">41598</td><td align="center">8581</td><td align="center">447</td></tr><tr><td align="center"><italic>PSSM</italic> + <italic>PSSs + VBPs</italic></td><td align="center">80.71</td><td align="center">85.14</td><td align="center">84.96</td><td align="center">0.35</td><td align="center">0.90</td><td align="center">1791</td><td align="center">42724</td><td align="center">7455</td><td align="center">428</td></tr><tr><td align="center" rowspan="2">DPLPI</td><td align="center"><italic>PSSM</italic></td><td align="center">90.38</td><td align="center">92.62</td><td align="center">92.53</td><td align="center">0.52</td><td align="center">0.96</td><td align="center">987</td><td align="center">24672</td><td align="center">1966</td><td align="center">105</td></tr><tr><td align="center"><italic>PSSM</italic> + <italic>PSSs + VBPs</italic></td><td align="center">91.48</td><td align="center">93.09</td><td align="center">93.03</td><td align="center">0.54</td><td align="center">0.97</td><td align="center">999</td><td align="center">24798</td><td align="center">1840</td><td align="center">93</td></tr></tbody></table></table-wrap><table-wrap id="Tab5"><label>Table 5</label><caption><p><bold>Performance comparisons between</bold><bold><italic>PSSM + PSSs</italic></bold> <bold>+</bold> <bold><italic>VBPs</italic></bold><bold>and</bold><bold><italic>PSSM</italic></bold><bold>on DVI, DVAI, DVBI, and DPLPI datasets over five-fold sequence-level cross-validation under</bold><bold><italic>MaxMCC Evaluation</italic></bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dataset</th><th>Feature</th><th><italic>Sn</italic>
(%)</th><th><italic>Sp</italic>
(%)</th><th><italic>Acc</italic>
(%)</th><th><italic>MCC</italic></th><th><italic>AUC</italic></th><th><italic>TP</italic></th><th><italic>TN</italic></th><th><italic>FP</italic></th><th><italic>FN</italic></th></tr></thead><tbody><tr><td align="center" rowspan="2">DVI</td><td align="center"><italic>PSSM</italic></td><td align="center">52.29</td><td align="center">98.32</td><td align="center">96.19</td><td align="center">0.54</td><td align="center">0.87</td><td align="center">1577</td><td align="center">61076</td><td align="center">1046</td><td align="center">1439</td></tr><tr><td align="center"><italic>PSSM + PSSs</italic> + <italic>VBPs</italic></td><td align="center">53.22</td><td align="center">98.32</td><td align="center">96.23</td><td align="center">0.55</td><td align="center">0.88</td><td align="center">1605</td><td align="center">61080</td><td align="center">1042</td><td align="center">1411</td></tr><tr><td align="center" rowspan="2">DVAI</td><td align="center"><italic>PSSM</italic></td><td align="center">40.15</td><td align="center">96.39</td><td align="center">92.57</td><td align="center">0.39</td><td align="center">0.82</td><td align="center">216</td><td align="center">7109</td><td align="center">267</td><td align="center">322</td></tr><tr><td align="center"><italic>PSSM + PSSs</italic> + <italic>VBPs</italic></td><td align="center">44.24</td><td align="center">96.61</td><td align="center">93.05</td><td align="center">0.43</td><td align="center">0.84</td><td align="center">238</td><td align="center">7126</td><td align="center">250</td><td align="center">300</td></tr><tr><td align="center" rowspan="2">DVBI</td><td align="center"><italic>PSSM</italic></td><td align="center">58.18</td><td align="center">98.40</td><td align="center">96.69</td><td align="center">0.58</td><td align="center">0.89</td><td align="center">1291</td><td align="center">49373</td><td align="center">806</td><td align="center">928</td></tr><tr><td align="center"><italic>PSSM + PSSs</italic> + <italic>VBPs</italic></td><td align="center">59.58</td><td align="center">98.33</td><td align="center">96.69</td><td align="center">0.59</td><td align="center">0.90</td><td align="center">1322</td><td align="center">49342</td><td align="center">837</td><td align="center">897</td></tr><tr><td align="center" rowspan="2">DPLPI</td><td align="center"><italic>PSSM</italic></td><td align="center">80.86</td><td align="center">99.07</td><td align="center">98.36</td><td align="center">0.79</td><td align="center">0.96</td><td align="center">883</td><td align="center">26391</td><td align="center">247</td><td align="center">209</td></tr><tr><td align="center"><italic>PSSM + PSSs</italic> + <italic>VBPs</italic></td><td align="center">81.32</td><td align="center">99.12</td><td align="center">98.42</td><td align="center">0.79</td><td align="center">0.97</td><td align="center">888</td><td align="center">26403</td><td align="center">235</td><td align="center">204</td></tr></tbody></table></table-wrap><fig id="Fig2"><label>Figure 2</label><caption><p><bold>ROC curves of the predictions with</bold><bold><italic>PSSM</italic></bold><bold>and</bold><bold><italic>PSSM</italic></bold> <bold>+</bold> <bold><italic>PSSs</italic></bold> <bold>+</bold> <bold><italic>VBPs</italic></bold><bold>features, respectively, on the DVI dataset over sequence-level five-fold cross-validation.</bold></p></caption><graphic xlink:href="12859_2014_6690_Fig2_HTML" id="d30e3293"/></fig></p>
      <p>We have also provided performance comparisons of different feature combinations in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1.</p>
    </sec>
    <sec id="Sec14">
      <title>Ensembling heterogeneous SVMs helps to improve the prediction performance</title>
      <p>In this section, we will empirically demonstrate that the prediction performance of protein-vitamin interactions can be further improved by ensembling multiple heterogeneous SVMs. More specifically, we adopted three feature selection methods (i.e., data variance [<xref ref-type="bibr" rid="CR49">49</xref>], Fisher score [<xref ref-type="bibr" rid="CR50">50</xref>], and Laplacian score [<xref ref-type="bibr" rid="CR51">51</xref>]) to select three different feature subsets from the original <italic>PSSM</italic> + <italic>PSSs</italic> + <italic>VBPs</italic> feature space; then, we trained three heterogeneous SVMs on the selected feature subsets. The final prediction was performed by averaging the outputs of the three trained SVMs. For comparison, we also directly trained an SVM with the original <italic>PSSM</italic> + <italic>PSSs</italic> + <italic>VBPs</italic> feature, denoted as no ensemble. Table <xref rid="Tab6" ref-type="table">6</xref> summarises the performance comparisons between ensemble and no ensemble on all the four considered datasets over sequence-level five-fold cross-validation under <italic>Balanced Evaluation</italic>. Figure <xref rid="Fig3" ref-type="fig">3</xref> illustrates the ROC curves of the predictions with ensemble and no ensemble, respectively, on the DVI dataset over sequence-level five-fold cross-validation.<table-wrap id="Tab6"><label>Table 6</label><caption><p><bold>Performance comparisons between with- and without-ensemble on DVI, DVAI, DVBI, and DPLPI datasets over five-fold sequence-level cross-validation under</bold><bold><italic>Balanced Evaluation</italic></bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dataset</th><th>Ensemble</th><th><italic>Sn</italic>
(%)</th><th><italic>Sp</italic>
(%)</th><th><italic>Acc</italic>
(%)</th><th><italic>MCC</italic></th><th><italic>AUC</italic></th><th><italic>TP</italic></th><th><italic>TN</italic></th><th><italic>FP</italic></th><th><italic>FN</italic></th></tr></thead><tbody><tr><td align="center" rowspan="2">DVI</td><td align="center">No</td><td align="center">78.55</td><td align="center">82.02</td><td align="center">81.86</td><td align="center">0.31</td><td align="center">0.88</td><td align="center">2369</td><td align="center">50951</td><td align="center">11171</td><td align="center">647</td></tr><tr><td align="center">Yes</td><td align="center">78.45</td><td align="center">84.17</td><td align="center">83.90</td><td align="center">0.34</td><td align="center">0.89</td><td align="center">2366</td><td align="center">52285</td><td align="center">9837</td><td align="center">650</td></tr><tr><td align="center" rowspan="2">DVAI</td><td align="center">No</td><td align="center">72.12</td><td align="center">78.28</td><td align="center">77.86</td><td align="center">0.29</td><td align="center">0.84</td><td align="center">388</td><td align="center">5774</td><td align="center">1602</td><td align="center">150</td></tr><tr><td align="center">Yes</td><td align="center">72.68</td><td align="center">79.89</td><td align="center">79.40</td><td align="center">0.31</td><td align="center">0.85</td><td align="center">391</td><td align="center">5893</td><td align="center">1483</td><td align="center">147</td></tr><tr><td align="center" rowspan="2">DVBI</td><td align="center">No</td><td align="center">80.71</td><td align="center">85.14</td><td align="center">84.96</td><td align="center">0.35</td><td align="center">0.90</td><td align="center">1791</td><td align="center">42724</td><td align="center">7455</td><td align="center">428</td></tr><tr><td align="center">Yes</td><td align="center">81.34</td><td align="center">85.49</td><td align="center">85.31</td><td align="center">0.36</td><td align="center">0.91</td><td align="center">1805</td><td align="center">42898</td><td align="center">7281</td><td align="center">414</td></tr><tr><td align="center" rowspan="2">DPLPI</td><td align="center">No</td><td align="center">91.48</td><td align="center">93.09</td><td align="center">93.03</td><td align="center">0.54</td><td align="center">0.97</td><td align="center">999</td><td align="center">24798</td><td align="center">1840</td><td align="center">93</td></tr><tr><td align="center">Yes</td><td align="center">91.30</td><td align="center">93.65</td><td align="center">93.56</td><td align="center">0.56</td><td align="center">0.97</td><td align="center">997</td><td align="center">24947</td><td align="center">1691</td><td align="center">95</td></tr></tbody></table></table-wrap><fig id="Fig3"><label>Figure 3</label><caption><p><bold>ROC curves of the predictions with ensemble and no ensemble, respectively, on the DVI dataset over sequence-level five-fold cross-validation.</bold></p></caption><graphic xlink:href="12859_2014_6690_Fig3_HTML" id="d30e3702"/></fig></p>
      <p>In Table <xref rid="Tab6" ref-type="table">6</xref>, it can be observed that the values of the five evaluation indexes (i.e., <italic>Sn</italic>, <italic>Sp</italic>, <italic>Acc</italic>, <italic>MCC</italic>, and <italic>AUC</italic>) of the prediction under ensemble are consistently superior to that of the prediction under no ensemble, with only two exceptions: <italic>Sn</italic> in the DVI and DPLPI datasets. The prediction under ensemble achieved average improvements of approximately 2% and 1% for <italic>MCC</italic> and <italic>AUC</italic>, respectively. The results demonstrate that the heterogeneous SVMs trained with different feature subsets can complement with each other, which accounts for the improvements in the prediction performance.</p>
    </sec>
    <sec id="Sec15">
      <title>Comparison with existing protein-vitamin interaction predictors</title>
      <p>In this section, we will compare the proposed method, called TargetVita, with existing predictors for protein-vitamin prediction. Note that in TargetVita, the <italic>PSSM</italic> + <italic>PSSs + VBPs</italic> feature was used as the input feature, and the SVM ensemble based on feature selection was applied. To the best of our knowledge, VitaPred [<xref ref-type="bibr" rid="CR30">30</xref>] is the only predictor that was specifically designed for protein-vitamin prediction; thus, we compare the proposed TargetVita with VitaPred under both a cross-validation test and an independent validation test.</p>
      <p>However, the cross-validation performance of VitaPred may have been overestimated because it was evaluated by performing residue-level cross-validation. In view of this, SVM-S, which is a re-implementation of VitaPred that was evaluated over sequence-level cross-validation, was taken to compare with the proposed TargetVita when performing the cross-validation test. As for the independent validation test, TargetVita will be compared with both VitaPred and the SVM-S.</p>
      <sec id="Sec16">
        <title>A. Cross-validation test</title>
        <p>Tables <xref rid="Tab7" ref-type="table">7</xref> and <xref rid="Tab8" ref-type="table">8</xref> illustrate the performance comparisons between TargetVita and SVM-S on the four datasets over five-fold sequence-level cross-validation under <italic>Balanced Evaluation</italic> and <italic>MaxMCC Evaluation</italic>, respectively. From Table <xref rid="Tab7" ref-type="table">7</xref>, we can see that the values of the five evaluation indexes for TargetVita are consistently superior to that of SVM-S throughout the four benchmark datasets. Taking <italic>MCC</italic> and <italic>AUC</italic> as examples, which are the two indexes measuring the overall prediction performance of a predictor, TargetVita clearly outperforms SVM-S, and average improvements of 3.5% and 2% were observed, respectively. Under <italic>MaxMCC Evaluation</italic> (refer to Table <xref rid="Tab8" ref-type="table">8</xref>), a similar phenomenon can also be observed, with only minor exceptions on <italic>Sn</italic>.<table-wrap id="Tab7"><label>Table 7</label><caption><p><bold>Performance comparisons with SVM-S on DVI, DVAI, DVBI, and DPLPI datasets over five-fold sequence-level cross-validation under</bold><bold><italic>Balanced Evaluation</italic></bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dataset</th><th>Method</th><th><italic>Sn</italic>
(%)</th><th><italic>Sp</italic>
(%)</th><th><italic>Acc</italic>
(%)</th><th><italic>MCC</italic></th><th><italic>AUC</italic></th><th><italic>TP</italic></th><th><italic>TN</italic></th><th><italic>FP</italic></th><th><italic>FN</italic></th></tr></thead><tbody><tr><td align="center" rowspan="2">DVI</td><td align="center">SVM-S<sup>△</sup>
</td><td align="center">77.65</td><td align="center">80.16</td><td align="center">80.04</td><td align="center">0.29</td><td align="center">0.87</td><td align="center">2342</td><td align="center">49797</td><td align="center">12325</td><td align="center">674</td></tr><tr><td align="center">TargetVita</td><td align="center">78.45</td><td align="center">84.17</td><td align="center">83.90</td><td align="center">0.34</td><td align="center">0.89</td><td align="center">2366</td><td align="center">52285</td><td align="center">9837</td><td align="center">650</td></tr><tr><td align="center" rowspan="2">DVAI</td><td align="center">SVM-S<sup>△</sup>
</td><td align="center">72.12</td><td align="center">76.34</td><td align="center">76.06</td><td align="center">0.28</td><td align="center">0.82</td><td align="center">388</td><td align="center">5631</td><td align="center">1745</td><td align="center">150</td></tr><tr><td align="center">TargetVita</td><td align="center">72.68</td><td align="center">79.89</td><td align="center">79.40</td><td align="center">0.31</td><td align="center">0.85</td><td align="center">391</td><td align="center">5893</td><td align="center">1483</td><td align="center">147</td></tr><tr><td align="center" rowspan="2">DVBI</td><td align="center">SVM-S<sup>△</sup>
</td><td align="center">79.86</td><td align="center">82.90</td><td align="center">82.77</td><td align="center">0.32</td><td align="center">0.89</td><td align="center">1772</td><td align="center">41598</td><td align="center">8581</td><td align="center">447</td></tr><tr><td align="center">TargetVita</td><td align="center">81.34</td><td align="center">85.49</td><td align="center">85.31</td><td align="center">0.36</td><td align="center">0.91</td><td align="center">1805</td><td align="center">42898</td><td align="center">7281</td><td align="center">414</td></tr><tr><td align="center" rowspan="2">DPLPI</td><td align="center">SVM-S<sup>△</sup>
</td><td align="center">90.38</td><td align="center">92.62</td><td align="center">92.53</td><td align="center">0.52</td><td align="center">0.96</td><td align="center">987</td><td align="center">24672</td><td align="center">1966</td><td align="center">105</td></tr><tr><td align="center">TargetVita</td><td align="center">91.30</td><td align="center">93.65</td><td align="center">93.56</td><td align="center">0.56</td><td align="center">0.97</td><td align="center">997</td><td align="center">24947</td><td align="center">1691</td><td align="center">95</td></tr></tbody></table><table-wrap-foot><p><sup>△</sup>SVM-S: The re-implementation of VitaPred over sequence-level cross-validation.</p></table-wrap-foot></table-wrap><table-wrap id="Tab8"><label>Table 8</label><caption><p><bold>Performance comparisons with existing predictors on DVI, DVAI, DVBI, and DPLPI datasets over five-fold sequence-level cross-validation under</bold><bold><italic>MaxMCC Evaluation</italic></bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dataset</th><th>Method</th><th><italic>Sn</italic>
(%)</th><th><italic>Sp</italic>
(%)</th><th><italic>Acc</italic>
(%)</th><th><italic>MCC</italic></th><th><italic>AUC</italic></th><th><italic>TP</italic></th><th><italic>TN</italic></th><th><italic>FP</italic></th><th><italic>FN</italic></th></tr></thead><tbody><tr><td align="center" rowspan="2">DVI</td><td align="center">SVM-S<sup>△</sup>
</td><td align="center">52.29</td><td align="center">98.32</td><td align="center">96.19</td><td align="center">0.54</td><td align="center">0.87</td><td align="center">1577</td><td align="center">61076</td><td align="center">1046</td><td align="center">1439</td></tr><tr><td align="center">TargetVita</td><td align="center">51.06</td><td align="center">98.59</td><td align="center">96.39</td><td align="center">0.55</td><td align="center">0.89</td><td align="center">1540</td><td align="center">61244</td><td align="center">878</td><td align="center">1476</td></tr><tr><td align="center" rowspan="2">DVAI</td><td align="center">SVM-S<sup>△</sup>
</td><td align="center">40.15</td><td align="center">96.39</td><td align="center">92.57</td><td align="center">0.39</td><td align="center">0.82</td><td align="center">216</td><td align="center">7109</td><td align="center">267</td><td align="center">322</td></tr><tr><td align="center">TargetVita</td><td align="center">44.43</td><td align="center">96.81</td><td align="center">93.25</td><td align="center">0.44</td><td align="center">0.85</td><td align="center">239</td><td align="center">7141</td><td align="center">235</td><td align="center">299</td></tr><tr><td align="center" rowspan="2">DVBI</td><td align="center">SVM-S<sup>△</sup>
</td><td align="center">58.18</td><td align="center">98.40</td><td align="center">96.69</td><td align="center">0.58</td><td align="center">0.89</td><td align="center">1291</td><td align="center">49373</td><td align="center">806</td><td align="center">928</td></tr><tr><td align="center">TargetVita</td><td align="center">56.21</td><td align="center">98.81</td><td align="center">97.02</td><td align="center">0.60</td><td align="center">0.91</td><td align="center">1248</td><td align="center">49582</td><td align="center">597</td><td align="center">971</td></tr><tr><td align="center">DPLPI</td><td align="center">SVM-S<sup>△</sup>
</td><td align="center">80.86</td><td align="center">99.07</td><td align="center">98.36</td><td align="center">0.79</td><td align="center">0.96</td><td align="center">883</td><td align="center">26391</td><td align="center">247</td><td align="center">209</td></tr><tr><td/><td align="center">TargetVita</td><td align="center">74.05</td><td align="center">99.61</td><td align="center">98.60</td><td align="center">0.80</td><td align="center">0.97</td><td align="center">812</td><td align="center">26534</td><td align="center">104</td><td align="center">280</td></tr></tbody></table><table-wrap-foot><p><sup>△</sup>SVM-S: The re-implementation of VitaPred over sequence-level cross-validation.</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec17">
        <title>B. Independent validation test</title>
        <p>Performing only cross-validation comparisons to demonstrate the effectiveness of a newly developed method over an existing method is often not convincing, the reason being that the characteristics of the new method may be <italic>over-fitted</italic> and/or <italic>over-optimised</italic> to the underlying dataset for the purpose of pursuing positive comparison results [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Validation on fresh independent data has been considered as an important and necessary procedure when comparing different methods, and it has been widely applied in related research.</p>
        <p>With this view, we also performed independent validation tests to further demonstrate the superiority of the proposed TargetVita over existing protein-vitamin predictors. Tables <xref rid="Tab9" ref-type="table">9</xref> and <xref rid="Tab10" ref-type="table">10</xref> summarise the performance comparisons between TargetVita and existing predictors on independent validation tests under <italic>Balanced Evaluation</italic> and <italic>MaxMCC Evaluation</italic>, respectively. From Tables <xref rid="Tab9" ref-type="table">9</xref> and <xref rid="Tab10" ref-type="table">10</xref>, two observations can be made as follows:<table-wrap id="Tab9"><label>Table 9</label><caption><p><bold>Performance comparisons with existing predictors on the independent validation datasets under</bold><bold><italic>Balanced Evaluation</italic></bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dataset</th><th>Method</th><th><italic>Sn</italic>
(%)</th><th><italic>Sp</italic>
(%)</th><th><italic>Acc</italic>
(%)</th><th><italic>MCC</italic></th><th><italic>AUC</italic></th><th><italic>TP</italic></th><th><italic>TN</italic></th><th><italic>FP</italic></th><th><italic>FN</italic></th></tr></thead><tbody><tr><td align="center" rowspan="3">DVI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">73.70</td><td align="center">71.98</td><td align="center">72.07</td><td align="center">0.22</td><td align="center">-</td><td align="center"><bold>-</bold></td><td align="center"><bold>-</bold></td><td align="center"><bold>-</bold></td><td align="center"><bold>-</bold></td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">75.38</td><td align="center">78.51</td><td align="center">78.35</td><td align="center">0.28</td><td align="center">0.85</td><td align="center">493</td><td align="center">9167</td><td align="center">2509</td><td align="center">161</td></tr><tr><td align="center">TargetVita</td><td align="center">80.73</td><td align="center">81.05</td><td align="center">81.03</td><td align="center">0.33</td><td align="center">0.89</td><td align="center">528</td><td align="center">9463</td><td align="center">2213</td><td align="center">126</td></tr><tr><td align="center" rowspan="3">DVAI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">73.48</td><td align="center">72.87</td><td align="center">72.93</td><td align="center">0.31</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">73.48</td><td align="center">79.25</td><td align="center">78.61</td><td align="center">0.38</td><td align="center">0.83</td><td align="center">133</td><td align="center">1142</td><td align="center">299</td><td align="center">48</td></tr><tr><td align="center">TargetVita</td><td align="center">79.01</td><td align="center">79.18</td><td align="center">79.16</td><td align="center">0.41</td><td align="center">0.86</td><td align="center">143</td><td align="center">1141</td><td align="center">300</td><td align="center">38</td></tr><tr><td align="center" rowspan="3">DVBI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">83.05</td><td align="center">68.76</td><td align="center">69.40</td><td align="center">0.23</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">78.28</td><td align="center">81.49</td><td align="center">81.35</td><td align="center">0.30</td><td align="center">0.88</td><td align="center">328</td><td align="center">7291</td><td align="center">1656</td><td align="center">91</td></tr><tr><td align="center">TargetVita</td><td align="center">81.38</td><td align="center">81.69</td><td align="center">81.68</td><td align="center">0.32</td><td align="center">0.90</td><td align="center">341</td><td align="center">7309</td><td align="center">1638</td><td align="center">78</td></tr><tr><td align="center" rowspan="2">DPLPI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">84.15</td><td align="center">83.22</td><td align="center">83.26</td><td align="center">0.33</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">85.77</td><td align="center">90.18</td><td align="center">90.00</td><td align="center">0.44</td><td align="center">0.95</td><td align="center">211</td><td align="center">5352</td><td align="center">583</td><td align="center">35</td></tr><tr><td/><td align="center">TargetVita</td><td align="center">89.02</td><td align="center">89.30</td><td align="center">89.29</td><td align="center">0.44</td><td align="center">0.96</td><td align="center">219</td><td align="center">5300</td><td align="center">635</td><td align="center">27</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>Data excepted from [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p><sup>△</sup>SVM-S: The re-implementation of VitaPred.</p></table-wrap-foot></table-wrap><table-wrap id="Tab10"><label>Table 10</label><caption><p><bold>Performance comparisons with existing predictors on the independent validation datasets under</bold><bold><italic>MaxMCC Evaluation</italic></bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dataset</th><th>Method</th><th><italic>Sn</italic>
(%)</th><th><italic>Sp</italic>
(%)</th><th><italic>Acc</italic>
(%)</th><th><italic>MCC</italic></th><th><italic>AUC</italic></th><th><italic>TP</italic></th><th><italic>TN</italic></th><th><italic>FP</italic></th><th><italic>FN</italic></th></tr></thead><tbody><tr><td align="center" rowspan="3">DVI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">41.74</td><td align="center">96.63</td><td align="center">93.72</td><td align="center">0.38</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">47.09</td><td align="center">98.40</td><td align="center">95.68</td><td align="center">0.52</td><td align="center">0.85</td><td align="center">308</td><td align="center">11489</td><td align="center">187</td><td align="center">346</td></tr><tr><td align="center">TargetVita</td><td align="center">47.01</td><td align="center">98.42</td><td align="center">95.69</td><td align="center">0.52</td><td align="center">0.89</td><td align="center">308</td><td align="center">11491</td><td align="center">185</td><td align="center">346</td></tr><tr><td align="center" rowspan="3">DVAI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">30.39</td><td align="center">97.22</td><td align="center">89.77</td><td align="center">0.37</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">32.04</td><td align="center">97.09</td><td align="center">89.83</td><td align="center">0.38</td><td align="center">0.83</td><td align="center">58</td><td align="center">1399</td><td align="center">42</td><td align="center">123</td></tr><tr><td align="center">TargetVita</td><td align="center">38.12</td><td align="center">96.81</td><td align="center">90.26</td><td align="center">0.43</td><td align="center">0.86</td><td align="center">69</td><td align="center">1395</td><td align="center">46</td><td align="center">112</td></tr><tr><td align="center" rowspan="3">DVBI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">49.40</td><td align="center">94.49</td><td align="center">92.47</td><td align="center">0.35</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">52.03</td><td align="center">98.25</td><td align="center">96.18</td><td align="center">0.53</td><td align="center">0.88</td><td align="center">218</td><td align="center">8790</td><td align="center">157</td><td align="center">201</td></tr><tr><td align="center">TargetVita</td><td align="center">51.06</td><td align="center">98.69</td><td align="center">96.56</td><td align="center">0.55</td><td align="center">0.90</td><td align="center">214</td><td align="center">8830</td><td align="center">117</td><td align="center">205</td></tr><tr><td align="center" rowspan="2">DPLPI</td><td align="center">VitaPred<sup>*</sup>
</td><td align="center">65.85</td><td align="center">98.40</td><td align="center">97.10</td><td align="center">0.63</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SVM-S<sup>△</sup>
</td><td align="center">72.76</td><td align="center">99.11</td><td align="center">98.06</td><td align="center">0.74</td><td align="center">0.95</td><td align="center">179</td><td align="center">5882</td><td align="center">53</td><td align="center">67</td></tr><tr><td/><td align="center">TargetVita</td><td align="center">74.39</td><td align="center">99.07</td><td align="center">98.09</td><td align="center">0.75</td><td align="center">0.96</td><td align="center">183</td><td align="center">5880</td><td align="center">55</td><td align="center">63</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>Data excepted from [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p><sup>△</sup>SVM-S: The re-implementation of VitaPred.</p></table-wrap-foot></table-wrap></p>
        <p>First, the proposed TargetVita significantly outperforms VitaPred under both <italic>Balanced Evaluation</italic> and <italic>MaxMCC Evaluation</italic>. Taking <italic>MCC</italic> as an example, TargetVita achieved approximately 9% ~ 11% and 6% ~ 20% improvements on the four independent validation datasets under <italic>Balanced Evaluation</italic> and <italic>MaxMCC Evaluation</italic>, respectively. In addition, TargetVita also outperformed SVM-S, which is a re-implementation of VitaPred, and acted as the best performer with an average improvement of approximately 2.5% for <italic>MCC</italic> if compared with the second best performer, SVM-S.</p>
        <p>Second, the values of <italic>MCC</italic> for VitaPred over the cross-validation test and independent validation test differ significantly under both the <italic>Balanced Evaluation</italic> and <italic>MaxMCC Evaluation</italic> if compared with TargetVita and SVM-S. In other words, the performance evaluated over the cross-validation test is significantly better than that evaluated over the independent validation test for VitaPred, while similar performances were obtained over the cross-validation test and the independent validation test for TargetVita and SVM-S.</p>
        <p>Taking the results under <italic>MaxMCC Evaluation</italic> as an example, the values of <italic>MCC</italic> over the cross-validation test for VitaPred are 0.53, 0.48, 0.61, and 0.81, respectively (refer to Table <xref rid="Tab3" ref-type="table">3</xref>), while the values of <italic>MCC</italic> over the independent validation test for VitaPred are 0.38, 0.37, 0.35, and 0.63, respectively (refer to Table <xref rid="Tab10" ref-type="table">10</xref>), for the four considered vitamins. Then, we can calculate that the <italic>MCC</italic> differences between the cross-validation test and the independent validation test of VitaPred for the four considered vitamins are 0.15, 0.11, 0.26, and 0.18, respectively. By revisiting Table <xref rid="Tab8" ref-type="table">8</xref>, together with Table <xref rid="Tab10" ref-type="table">10</xref>, we calculate that the <italic>MCC</italic> differences between the cross-validation test and the independent validation test of the proposed TargetVita for the four considered vitamins are only 0.03, 0.01, 0.05, and 0.05, respectively. Similarly, the <italic>MCC</italic> differences of SVM-S can also be calculated from Table <xref rid="Tab3" ref-type="table">3</xref> and Table <xref rid="Tab10" ref-type="table">10</xref>. Figure <xref rid="Fig4" ref-type="fig">4</xref> illustrates the differences between the <italic>MCC</italic> values over the cross-validation test and the independent validation test for VitaPred, SVM-S, and TargetVita on the four considered vitamins under <italic>MaxMCC Evaluation</italic>. Note that in Figure <xref rid="Fig4" ref-type="fig">4</xref>, <italic>d</italic><sub><italic>V</italic></sub>, <italic>d</italic><sub><italic>S</italic></sub>, and <italic>d</italic><sub><italic>T</italic></sub> denote the <italic>MCC</italic> differences for VitaPred, SVM-S, and TargetVita, respectively, and only the <italic>MCC</italic> differences on the DPLPI dataset are explicitly labelled.<fig id="Fig4"><label>Figure 4</label><caption><p><bold>Differences between the</bold><bold><italic>MCC</italic></bold><bold>values over the cross-validation test and over the independent validation test for VitaPred, SVM-S, and TargetVita on the four considered vitamins under</bold><bold><italic>MaxMCC Evaluation</italic></bold><bold>.</bold></p></caption><graphic xlink:href="12859_2014_6690_Fig4_HTML" id="d30e5733"/></fig></p>
        <p>From Figure <xref rid="Fig4" ref-type="fig">4</xref>, we can intuitively find that the proposed TargetVita and SVM-S achieve similar performances (in terms of <italic>MCC</italic>) over both the cross-validation test and independent validation test, as their <italic>MCC</italic> differences are small, while the performance of VitaPred over the independent validation test is significantly lower than that that over the cross-validation test with all four considered vitamins, indicating that the performance of VitaPred over the cross-validation test has potentially been over-estimated or over-optimised, thus leading to a lower generalisation capability (i.e., poor performance with independent fresh data). This observation further supports the speculation (i.e., the <italic>MCC</italic> of VitaPred has potentially been over-estimated) we made in a previous section.</p>
      </sec>
      <sec id="Sec18">
        <title>C. Performance on a non-vitamin binding dataset</title>
        <p>We then performed performance comparisons between the proposed TargetVita and VitaPred on the non-vitamin binding dataset NVD, and the results of the comparison are listed in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2. Note that the results of VitaPred and TargetVita were obtained by feeding the 6676 sequences to their corresponding web servers with default threshold settings.</p>
        <p>From Table S2, we can clearly see that the proposed TargetVita achieved much better prediction performance than VitaPred. Among the 1852390 residues in the 6676 non-vitamin binding sequences, 46319 residues were mistakenly predicted as binding residues by VitaPred, while only 36361 false positives were obtained by TargetVita.</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec19" sec-type="conclusions">
    <title>Conclusions</title>
    <p>In this study, we have designed and implemented a new sequence-based predictor, called TargetVita, for protein-vitamin binding residue prediction. TargetVita performs prediction by utilising multiple features derived from protein sequences and effectively ensembling heterogeneous SVMs trained on different feature subspaces. Experimental results on benchmark datasets demonstrated that the proposed TargetVita can achieve good performance and is superior to existing protein-vitamin binding residue predictors.</p>
    <p>Our future work will focus on further improving the prediction performance of TargetVita by uncovering new effective feature sources and applying more powerful machine-learning algorithms.</p>
    <sec id="Sec20">
      <title>Availability of supporting data</title>
      <p>The data sets supporting the results of this article are included within the Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Electronic supplementary material</title>
    <sec id="Sec21">
      <supplementary-material content-type="local-data" id="MOESM1">
        <media xlink:href="12859_2014_6690_MOESM1_ESM.pdf">
          <caption>
            <p>Additional file 1:
<bold>Datasets used in this study.</bold>
(PDF 191 KB)</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM2">
        <media xlink:href="12859_2014_6690_MOESM2_ESM.pdf">
          <caption>
            <p>Additional file 2: <bold>Table S1.</bold> Performance comparisons of different feature combinations over 5-fold sequence-level cross-validation under <italic>MaxMCC Evaluation</italic>. <bold>Table S2.</bold> Performance comparisons between the proposed TargetVita and VitaPred on the non-vitamin binding dataset NVD. (PDF 165 KB)</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Competing interests</bold>
      </p>
      <p>The authors declare that they have no competing interests.</p>
    </fn>
    <fn>
      <p>
        <bold>Authors’ contributions</bold>
      </p>
      <p>Conception and design: DJY, JH, HY, XBY, HBS, JYY; Acquisition of data: JH, DJY, HBS; Analysis of data: DJY, JH, YH, XBY, HBS, JYY; Writing and revising the manuscript: DJY, JH, HY, XBY, HBS. All authors read and approved the final manuscript.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>This work was supported by the National Natural Science Foundation of China (No. 61373062, 61175024, 61222306, 61100116, and 61233011), the Natural Science Foundation of Jiangsu (No. BK20141403), China Postdoctoral Science Foundation (No. 2013M530260, 2014T70526), "The Six Top Talents" of Jiangsu Province (No. 2013-XXRJ-022), and the Fundamental Research Funds for the Central Universities (No. 30920130111010).</p>
  </ack>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knowles</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gromo</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>A guide to drug discovery: target selection in drug discovery</article-title>
        <source>Nat Rev Drug Discov</source>
        <year>2003</year>
        <volume>2</volume>
        <issue>1</issue>
        <fpage>63</fpage>
        <lpage>69</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd986</pub-id>
        <?supplied-pmid 12509760?>
        <pub-id pub-id-type="pmid">12509760</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Skolnick</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>The distribution of ligand-binding pockets around protein-protein interfaces suggests a general mechanism for pocket formation</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <year>2012</year>
        <volume>109</volume>
        <issue>10</issue>
        <fpage>3784</fpage>
        <lpage>3789</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1117768109</pub-id>
        <?supplied-pmid 22355140?>
        <pub-id pub-id-type="pmid">22355140</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>De Las Rivas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fontanillo</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Protein-protein interactions essentials: key concepts to building and analyzing interactome networks</article-title>
        <source>PLoS Comput Biol</source>
        <year>2010</year>
        <volume>6</volume>
        <issue>6</issue>
        <fpage>e1000807</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1000807</pub-id>
        <?supplied-pmid 20589078?>
        <pub-id pub-id-type="pmid">20589078</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Casari</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Valencia</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>A method to predict functional residues in proteins</article-title>
        <source>Nat Struct Biol</source>
        <year>1995</year>
        <volume>2</volume>
        <issue>2</issue>
        <fpage>171</fpage>
        <lpage>178</lpage>
        <pub-id pub-id-type="doi">10.1038/nsb0295-171</pub-id>
        <?supplied-pmid 7749921?>
        <pub-id pub-id-type="pmid">7749921</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Peterson</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>XW</given-names>
          </name>
        </person-group>
        <article-title>Machine learning in biomedicine and bioinformatics</article-title>
        <source>Int J Data Min Bioinform</source>
        <year>2009</year>
        <volume>3</volume>
        <issue>4</issue>
        <fpage>363</fpage>
        <lpage>364</lpage>
        <pub-id pub-id-type="doi">10.1504/IJDMB.2009.029202</pub-id>
        <?supplied-pmid 20052901?>
        <pub-id pub-id-type="pmid">20052901</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Inza</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Calvo</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Armananzas</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bengoetxea</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Larranaga</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lozano</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Machine learning: an indispensable tool in bioinformatics</article-title>
        <source>Methods Mol Biol</source>
        <year>2010</year>
        <volume>593</volume>
        <fpage>25</fpage>
        <lpage>48</lpage>
        <pub-id pub-id-type="doi">10.1007/978-1-60327-194-3_2</pub-id>
        <?supplied-pmid 19957143?>
        <pub-id pub-id-type="pmid">19957143</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Larranaga</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Calvo</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Santana</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bielza</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Galdiano</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Inza</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lozano</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Armananzas</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Santafe</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Perez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Robles</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>Machine learning in bioinformatics</article-title>
        <source>Brief Bioinform</source>
        <year>2006</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>86</fpage>
        <lpage>112</lpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbk007</pub-id>
        <?supplied-pmid 16761367?>
        <pub-id pub-id-type="pmid">16761367</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Alberts</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <source>Molecular biology of the cell</source>
        <year>2008</year>
        <edition>5</edition>
        <publisher-loc>New York</publisher-loc>
        <publisher-name>Garland Science</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kokubo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Okamoto</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Ab initio prediction of protein-ligand binding structures by replica-exchange umbrella sampling simulations</article-title>
        <source>J Comput Chem</source>
        <year>2011</year>
        <volume>32</volume>
        <issue>13</issue>
        <fpage>2810</fpage>
        <lpage>2821</lpage>
        <pub-id pub-id-type="doi">10.1002/jcc.21860</pub-id>
        <?supplied-pmid 21710634?>
        <pub-id pub-id-type="pmid">21710634</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sousa</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>Fernandes</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Ramos</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>Protein-ligand docking: current status and future challenges</article-title>
        <source>Proteins</source>
        <year>2006</year>
        <volume>65</volume>
        <issue>1</issue>
        <fpage>15</fpage>
        <lpage>26</lpage>
        <pub-id pub-id-type="doi">10.1002/prot.21082</pub-id>
        <?supplied-pmid 16862531?>
        <pub-id pub-id-type="pmid">16862531</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hendlich</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rippmann</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Barnickel</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins</article-title>
        <source>J Mol Graph Model</source>
        <year>1997</year>
        <volume>15</volume>
        <issue>6</issue>
        <fpage>359</fpage>
        <lpage>363</lpage>
        <pub-id pub-id-type="doi">10.1016/S1093-3263(98)00002-3</pub-id>
        <?supplied-pmid 9704298?>
        <pub-id pub-id-type="pmid">9704298</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dundas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ouyang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Binkowski</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Turpaz</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues</article-title>
        <source>Nucleic Acids Res</source>
        <year>2006</year>
        <volume>34</volume>
        <issue>Web Server issue</issue>
        <fpage>W116</fpage>
        <lpage>W118</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkl282</pub-id>
        <?supplied-pmid 16844972?>
        <pub-id pub-id-type="pmid">16844972</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Laskowski</surname>
            <given-names>RA</given-names>
          </name>
        </person-group>
        <article-title>SURFNET: a program for visualizing molecular surfaces, cavities, and intermolecular interactions</article-title>
        <source>J Mol Graph</source>
        <year>1995</year>
        <volume>13</volume>
        <issue>5</issue>
        <fpage>323</fpage>
        <lpage>330</lpage>
        <pub-id pub-id-type="doi">10.1016/0263-7855(95)00073-9</pub-id>
        <?supplied-pmid 8603061?>
        <pub-id pub-id-type="pmid">8603061</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Levitt</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Banaszak</surname>
            <given-names>LJ</given-names>
          </name>
        </person-group>
        <article-title>POCKET: a computer graphics method for identifying and displaying protein cavities and their surrounding amino acids</article-title>
        <source>J Mol Graph</source>
        <year>1992</year>
        <volume>10</volume>
        <issue>4</issue>
        <fpage>229</fpage>
        <lpage>234</lpage>
        <pub-id pub-id-type="doi">10.1016/0263-7855(92)80074-N</pub-id>
        <?supplied-pmid 1476996?>
        <pub-id pub-id-type="pmid">1476996</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Le Guilloux</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Schmidtke</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tuffery</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Fpocket: an open source platform for ligand pocket detection</article-title>
        <source>BMC Bioinfor</source>
        <year>2009</year>
        <volume>10</volume>
        <fpage>168</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-10-168</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Laurie</surname>
            <given-names>AT</given-names>
          </name>
          <name>
            <surname>Jackson</surname>
            <given-names>RM</given-names>
          </name>
        </person-group>
        <article-title>Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites</article-title>
        <source>Bioinformatics</source>
        <year>2005</year>
        <volume>21</volume>
        <issue>9</issue>
        <fpage>1908</fpage>
        <lpage>1916</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bti315</pub-id>
        <?supplied-pmid 15701681?>
        <pub-id pub-id-type="pmid">15701681</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hernandez</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ghersi</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sanchez</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>SITEHOUND-web: a server for ligand binding site identification in protein structures</article-title>
        <source>Nucleic Acids Res</source>
        <year>2009</year>
        <volume>37</volume>
        <issue>Web Server issue</issue>
        <fpage>W413</fpage>
        <lpage>W416</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkp281</pub-id>
        <?supplied-pmid 19398430?>
        <pub-id pub-id-type="pmid">19398430</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Henrich</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Salo-Ahen</surname>
            <given-names>OM</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Rippmann</surname>
            <given-names>FF</given-names>
          </name>
          <name>
            <surname>Cruciani</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wade</surname>
            <given-names>RC</given-names>
          </name>
        </person-group>
        <article-title>Computational approaches to identifying and characterizing protein binding sites for ligand design</article-title>
        <source>J Mol Recognit</source>
        <year>2010</year>
        <volume>23</volume>
        <issue>2</issue>
        <fpage>209</fpage>
        <lpage>219</lpage>
        <?supplied-pmid 19746440?>
        <pub-id pub-id-type="pmid">19746440</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gromiha</surname>
            <given-names>MM</given-names>
          </name>
        </person-group>
        <article-title>Development of RNA stiffness parameters and analysis on protein-RNA binding specificity: comparison with DNA</article-title>
        <source>Curr Bioinform</source>
        <year>2012</year>
        <volume>7</volume>
        <issue>2</issue>
        <fpage>173</fpage>
        <lpage>179</lpage>
        <pub-id pub-id-type="doi">10.2174/157489312800604408</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mizianty</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Kurgan</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Prediction and analysis of nucleotide-binding residues using sequence and sequence-derived structural descriptors</article-title>
        <source>Bioinformatics</source>
        <year>2012</year>
        <volume>28</volume>
        <issue>3</issue>
        <fpage>331</fpage>
        <lpage>341</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btr657</pub-id>
        <?supplied-pmid 22130595?>
        <pub-id pub-id-type="pmid">22130595</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Designing template-free predictor for targeting protein-ligand binding sites with classifier ensemble and spatial clustering</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform</source>
        <year>2013</year>
        <volume>10</volume>
        <issue>4</issue>
        <fpage>994</fpage>
        <lpage>1008</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2013.104</pub-id>
        <?supplied-pmid 24334392?>
        <pub-id pub-id-type="pmid">24334392</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brylinski</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Skolnick</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>FINDSITE-metal: integrating evolutionary information and machine learning for structure-based metal-binding site prediction at the proteome level</article-title>
        <source>Proteins</source>
        <year>2011</year>
        <volume>79</volume>
        <issue>3</issue>
        <fpage>735</fpage>
        <lpage>751</lpage>
        <pub-id pub-id-type="doi">10.1002/prot.22913</pub-id>
        <?supplied-pmid 21287609?>
        <pub-id pub-id-type="pmid">21287609</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Babor</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gerzon</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Raveh</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sobolev</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Edelman</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Prediction of transition metal-binding sites from apo protein structures</article-title>
        <source>Proteins</source>
        <year>2008</year>
        <volume>70</volume>
        <issue>1</issue>
        <fpage>208</fpage>
        <lpage>217</lpage>
        <pub-id pub-id-type="doi">10.1002/prot.21587</pub-id>
        <?supplied-pmid 17657805?>
        <pub-id pub-id-type="pmid">17657805</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Si</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Schroeder</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>MetaDBSite: a meta approach to improve protein DNA-binding sites prediction</article-title>
        <source>BMC Syst Biol</source>
        <year>2011</year>
        <volume>5</volume>
        <issue>Suppl 1</issue>
        <fpage>S7</fpage>
        <pub-id pub-id-type="doi">10.1186/1752-0509-5-S1-S7</pub-id>
        <?supplied-pmid 21689482?>
        <pub-id pub-id-type="pmid">21689482</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Sequence-based prediction of DNA-binding residues in proteins with conservation and correlation information</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform</source>
        <year>2012</year>
        <volume>9</volume>
        <issue>6</issue>
        <fpage>1766</fpage>
        <lpage>1775</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2012.106</pub-id>
        <?supplied-pmid 22868682?>
        <pub-id pub-id-type="pmid">22868682</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schmidtke</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Barril</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Understanding and predicting druggability. A high-throughput method for detection of drug binding sites</article-title>
        <source>J Med Chem</source>
        <year>2010</year>
        <volume>53</volume>
        <issue>15</issue>
        <fpage>5858</fpage>
        <lpage>5867</lpage>
        <pub-id pub-id-type="doi">10.1021/jm100574m</pub-id>
        <?supplied-pmid 20684613?>
        <pub-id pub-id-type="pmid">20684613</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rebeille</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ravanel</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Marquet</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mendel</surname>
            <given-names>RR</given-names>
          </name>
          <name>
            <surname>Webb</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Warren</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>Roles of vitamins B5, B8, B9, B12 and molybdenum cofactor at cellular and organismal levels</article-title>
        <source>Nat Prod Rep</source>
        <year>2007</year>
        <volume>24</volume>
        <issue>5</issue>
        <fpage>949</fpage>
        <lpage>962</lpage>
        <pub-id pub-id-type="doi">10.1039/b703104c</pub-id>
        <?supplied-pmid 17898891?>
        <pub-id pub-id-type="pmid">17898891</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Webb</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Marquet</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mendel</surname>
            <given-names>RR</given-names>
          </name>
          <name>
            <surname>Rebeille</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>AG</given-names>
          </name>
        </person-group>
        <article-title>Elucidating biosynthetic pathways for vitamins and cofactors</article-title>
        <source>Nat Prod Rep</source>
        <year>2007</year>
        <volume>24</volume>
        <issue>5</issue>
        <fpage>988</fpage>
        <lpage>1008</lpage>
        <pub-id pub-id-type="doi">10.1039/b703105j</pub-id>
        <?supplied-pmid 17898894?>
        <pub-id pub-id-type="pmid">17898894</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dick</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Manjunatha</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Kappes</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Gengenbacher</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis</article-title>
        <source>Mol Microbiol</source>
        <year>2010</year>
        <volume>78</volume>
        <issue>4</issue>
        <fpage>980</fpage>
        <lpage>988</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07381.x</pub-id>
        <?supplied-pmid 20815826?>
        <pub-id pub-id-type="pmid">20815826</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Panwar</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>GPS</given-names>
          </name>
        </person-group>
        <article-title>Prediction of vitamin interacting residues in a vitamin binding protein using evolutionary information</article-title>
        <source>BMC Bioinform</source>
        <year>2013</year>
        <volume>14</volume>
        <issue>1</issue>
        <fpage>44</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-14-44</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bauer</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Günther</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jansen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Heeger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Thaben</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Preissner</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>SuperSite: dictionary of metabolite and drug binding sites in proteins</article-title>
        <source>Nucleic Acids Res</source>
        <year>2009</year>
        <volume>37</volume>
        <issue>suppl 1</issue>
        <fpage>D195</fpage>
        <lpage>D200</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkn618</pub-id>
        <?supplied-pmid 18842629?>
        <pub-id pub-id-type="pmid">18842629</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Westbrook</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gilliland</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>TN</given-names>
          </name>
          <name>
            <surname>Weissig</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shindyalov</surname>
            <given-names>IN</given-names>
          </name>
          <name>
            <surname>Bourne</surname>
            <given-names>PE</given-names>
          </name>
        </person-group>
        <article-title>The protein data bank</article-title>
        <source>Nucleic Acids Res</source>
        <year>2000</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>235</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>
        <?supplied-pmid 10592235?>
        <pub-id pub-id-type="pmid">10592235</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sobolev</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Sorokine</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Prilusky</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Abola</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>Edelman</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Automated analysis of interatomic contacts in proteins</article-title>
        <source>Bioinformatics</source>
        <year>1999</year>
        <volume>15</volume>
        <issue>4</issue>
        <fpage>327</fpage>
        <lpage>332</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/15.4.327</pub-id>
        <?supplied-pmid 10320401?>
        <pub-id pub-id-type="pmid">10320401</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Altschul</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>Madden</surname>
            <given-names>TL</given-names>
          </name>
          <name>
            <surname>Schaffer</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Lipman</surname>
            <given-names>DJ</given-names>
          </name>
        </person-group>
        <article-title>Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</article-title>
        <source>Nucleic Acids Res</source>
        <year>1997</year>
        <volume>25</volume>
        <issue>17</issue>
        <fpage>3389</fpage>
        <lpage>3402</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/25.17.3389</pub-id>
        <?supplied-pmid 9254694?>
        <pub-id pub-id-type="pmid">9254694</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Roy</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions</article-title>
        <source>Nucleic Acids Res</source>
        <year>2013</year>
        <volume>41</volume>
        <issue>D1</issue>
        <fpage>D1096</fpage>
        <lpage>D1103</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks966</pub-id>
        <?supplied-pmid 23087378?>
        <pub-id pub-id-type="pmid">23087378</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Godzik</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences</article-title>
        <source>Bioinformatics</source>
        <year>2006</year>
        <volume>22</volume>
        <issue>13</issue>
        <fpage>1658</fpage>
        <lpage>1659</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btl158</pub-id>
        <?supplied-pmid 16731699?>
        <pub-id pub-id-type="pmid">16731699</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>HB</given-names>
          </name>
          <name>
            <surname>Qi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>ZM</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JY</given-names>
          </name>
        </person-group>
        <article-title>TargetATPsite: a template-free method for ATP-binding sites prediction with residue evolution image sparse representation and classifier ensemble</article-title>
        <source>J Comput Chem</source>
        <year>2013</year>
        <volume>34</volume>
        <issue>11</issue>
        <fpage>974</fpage>
        <lpage>985</lpage>
        <pub-id pub-id-type="doi">10.1002/jcc.23219</pub-id>
        <?supplied-pmid 23288787?>
        <pub-id pub-id-type="pmid">23288787</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>ZM</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>HB</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>JY</given-names>
          </name>
        </person-group>
        <article-title>Improving protein-ATP binding residues prediction by boosting SVMs with random under-sampling</article-title>
        <source>Neurocomputing</source>
        <year>2013</year>
        <volume>104</volume>
        <fpage>180</fpage>
        <lpage>190</lpage>
        <pub-id pub-id-type="doi">10.1016/j.neucom.2012.10.012</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Firoz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Malik</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Joplin</surname>
            <given-names>KH</given-names>
          </name>
          <name>
            <surname>Ahmad</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Jha</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Ahmad</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Residue propensities, discrimination and binding site prediction of adenine and guanine phosphates</article-title>
        <source>BMC Biochem</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>20</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2091-12-20</pub-id>
        <?supplied-pmid 21569447?>
        <pub-id pub-id-type="pmid">21569447</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mizianty</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Kurgan</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>ATPsite: sequence-based prediction of ATP-binding residues</article-title>
        <source>Proteome Sci</source>
        <year>2011</year>
        <volume>9</volume>
        <issue>Suppl 1</issue>
        <fpage>S4</fpage>
        <pub-id pub-id-type="doi">10.1186/1477-5956-9-S1-S4</pub-id>
        <?supplied-pmid 22165846?>
        <pub-id pub-id-type="pmid">22165846</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schaffer</surname>
            <given-names>AA</given-names>
          </name>
        </person-group>
        <article-title>Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements</article-title>
        <source>Nucleic Acids Res</source>
        <year>2001</year>
        <volume>29</volume>
        <fpage>2994</fpage>
        <lpage>3005</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/29.14.2994</pub-id>
        <?supplied-pmid 11452024?>
        <pub-id pub-id-type="pmid">11452024</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>YN</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>YX</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>HB</given-names>
          </name>
        </person-group>
        <article-title>Predicting protein-ATP binding sites from primary sequence through fusing bi-profile sampling of multi-view features</article-title>
        <source>BMC Bioinform</source>
        <year>2012</year>
        <volume>13</volume>
        <fpage>118</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-13-118</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jones</surname>
            <given-names>DT</given-names>
          </name>
        </person-group>
        <article-title>Protein secondary structure prediction based on position-specific scoring matrices</article-title>
        <source>J Mol Biol</source>
        <year>1999</year>
        <volume>292</volume>
        <issue>2</issue>
        <fpage>195</fpage>
        <lpage>202</lpage>
        <pub-id pub-id-type="doi">10.1006/jmbi.1999.3091</pub-id>
        <?supplied-pmid 10493868?>
        <pub-id pub-id-type="pmid">10493868</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Saeys</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Inza</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Larranaga</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>A review of feature selection techniques in bioinformatics</article-title>
        <source>Bioinformatics</source>
        <year>2007</year>
        <volume>23</volume>
        <issue>19</issue>
        <fpage>2507</fpage>
        <lpage>2517</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btm344</pub-id>
        <?supplied-pmid 17720704?>
        <pub-id pub-id-type="pmid">17720704</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tadesse</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Vannucci</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Liò</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Identification of DNA regulatory motifs using Bayesian variable selection</article-title>
        <source>Bioinformatics</source>
        <year>2004</year>
        <volume>20</volume>
        <issue>16</issue>
        <fpage>2553</fpage>
        <lpage>2561</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bth282</pub-id>
        <?supplied-pmid 15117754?>
        <pub-id pub-id-type="pmid">15117754</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Saeys</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Degroeve</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Aeyels</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Rouze</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Van de Peer</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Feature selection for splice site prediction: a new method using EDA-based feature ranking</article-title>
        <source>BMC Bioinform</source>
        <year>2004</year>
        <volume>5</volume>
        <issue>1</issue>
        <fpage>64</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-5-64</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Statnikov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Aliferis</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Tsamardinos</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Hardin</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Levy</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis</article-title>
        <source>Bioinformatics</source>
        <year>2005</year>
        <volume>21</volume>
        <issue>5</issue>
        <fpage>631</fpage>
        <lpage>643</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bti033</pub-id>
        <?supplied-pmid 15374862?>
        <pub-id pub-id-type="pmid">15374862</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gevaert</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Smet</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Timmerman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Moreau</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Moor</surname>
            <given-names>BD</given-names>
          </name>
        </person-group>
        <article-title>Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks</article-title>
        <source>Bioinformatics</source>
        <year>2006</year>
        <volume>22</volume>
        <issue>14</issue>
        <fpage>e184</fpage>
        <lpage>e190</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btl230</pub-id>
        <?supplied-pmid 16873470?>
        <pub-id pub-id-type="pmid">16873470</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>HB</given-names>
          </name>
        </person-group>
        <article-title>Improving the accuracy of predicting disulfide connectivity by feature selection</article-title>
        <source>J Comput Chem</source>
        <year>2010</year>
        <volume>31</volume>
        <issue>7</issue>
        <fpage>1478</fpage>
        <lpage>1485</lpage>
        <?supplied-pmid 20127740?>
        <pub-id pub-id-type="pmid">20127740</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Richard</surname>
            <given-names>OD</given-names>
          </name>
          <name>
            <surname>Peter</surname>
            <given-names>EH</given-names>
          </name>
          <name>
            <surname>David</surname>
            <given-names>GS</given-names>
          </name>
        </person-group>
        <source>Pattern classification</source>
        <year>2001</year>
        <edition>2</edition>
        <publisher-loc>New York, USA</publisher-loc>
        <publisher-name>John Wiley &amp; Sons</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Niyogi</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Laplacian score for feature selection</article-title>
        <source>Advances in neural information processing systems</source>
        <year>2005</year>
        <publisher-loc>Vancouver, British Columbia, Canada</publisher-loc>
        <publisher-name>MIT Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yan</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Joint Laplacian feature weights learning</article-title>
        <source>Pattern Recogn</source>
        <year>2014</year>
        <volume>47</volume>
        <issue>3</issue>
        <fpage>1425</fpage>
        <lpage>1432</lpage>
        <pub-id pub-id-type="doi">10.1016/j.patcog.2013.09.038</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Vapnik</surname>
            <given-names>VN</given-names>
          </name>
        </person-group>
        <source>Statistical learning theory</source>
        <year>1998</year>
        <publisher-loc>New York</publisher-loc>
        <publisher-name>Wiley-Interscience</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fan</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>CJ</given-names>
          </name>
        </person-group>
        <article-title>Working set selection using second order information for training SVM</article-title>
        <source>J Mach Learn Res</source>
        <year>2005</year>
        <volume>6</volume>
        <fpage>1889</fpage>
        <lpage>1918</lpage>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Marti-Renom</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Fiser</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sanchez</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Melo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Sali</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Comparative protein structure modeling of genes and genomes</article-title>
        <source>Annu Rev Biophys Biomol Struct</source>
        <year>2000</year>
        <volume>29</volume>
        <fpage>291</fpage>
        <lpage>325</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev.biophys.29.1.291</pub-id>
        <?supplied-pmid 10940251?>
        <pub-id pub-id-type="pmid">10940251</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>CT</given-names>
          </name>
        </person-group>
        <article-title>Prediction of protein structural classes</article-title>
        <source>Crit Rev Biochem Mol Biol</source>
        <year>1995</year>
        <volume>30</volume>
        <issue>4</issue>
        <fpage>275</fpage>
        <lpage>349</lpage>
        <pub-id pub-id-type="doi">10.3109/10409239509083488</pub-id>
        <?supplied-pmid 7587280?>
        <pub-id pub-id-type="pmid">7587280</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Qi</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Enhancing membrane protein subcellular localization prediction by parallel fusion of multi-view features</article-title>
        <source>IEEE Trans Nanobiosci</source>
        <year>2012</year>
        <volume>11</volume>
        <issue>4</issue>
        <fpage>375</fpage>
        <lpage>385</lpage>
        <pub-id pub-id-type="doi">10.1109/TNB.2012.2208473</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>HB</given-names>
          </name>
        </person-group>
        <article-title>Cell-PLoc 2.0: an improved package of web-servers for predicting subcellular localization of proteins in various organisms</article-title>
        <source>Nat Sci</source>
        <year>2010</year>
        <volume>2</volume>
        <issue>10</issue>
        <fpage>1090</fpage>
        <lpage>1103</lpage>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>KC</given-names>
          </name>
        </person-group>
        <article-title>Some remarks on protein attribute prediction and pseudo amino acid composition</article-title>
        <source>J Theor Biol</source>
        <year>2011</year>
        <volume>273</volume>
        <issue>1</issue>
        <fpage>236</fpage>
        <lpage>247</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jtbi.2010.12.024</pub-id>
        <?supplied-pmid 21168420?>
        <pub-id pub-id-type="pmid">21168420</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>YD</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>KC</given-names>
          </name>
        </person-group>
        <article-title>Classification and analysis of regulatory pathways using graph property, biochemical and physicochemical property, and functional property</article-title>
        <source>PLoS One</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>9</issue>
        <fpage>e25297</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0025297</pub-id>
        <?supplied-pmid 21980418?>
        <pub-id pub-id-type="pmid">21980418</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>HB</given-names>
          </name>
        </person-group>
        <article-title>Cell-PLoc: a package of Web servers for predicting subcellular localization of proteins in various organisms</article-title>
        <source>Nat Protoc</source>
        <year>2008</year>
        <volume>3</volume>
        <issue>2</issue>
        <fpage>153</fpage>
        <lpage>162</lpage>
        <pub-id pub-id-type="doi">10.1038/nprot.2007.494</pub-id>
        <?supplied-pmid 18274516?>
        <pub-id pub-id-type="pmid">18274516</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boulesteix</surname>
            <given-names>AL</given-names>
          </name>
        </person-group>
        <article-title>Over-optimism in bioinformatics research</article-title>
        <source>Bioinformatics</source>
        <year>2010</year>
        <volume>26</volume>
        <issue>3</issue>
        <fpage>437</fpage>
        <lpage>439</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btp648</pub-id>
        <?supplied-pmid 19942585?>
        <pub-id pub-id-type="pmid">19942585</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sterlinga</surname>
            <given-names>TD</given-names>
          </name>
        </person-group>
        <article-title>Publication decisions and their possible effects on inferences drawn from tests of significance - or vice versa</article-title>
        <source>J Am Stat Assoc</source>
        <year>1959</year>
        <volume>54</volume>
        <issue>285</issue>
        <fpage>30</fpage>
        <lpage>34</lpage>
      </element-citation>
    </ref>
  </ref-list>
</back>
